Fungicidal active compound combinations

ABSTRACT

Safeners for herbicides are suitable for increasing the microbicidal activity of fungicides.

The invention relates to the use of safeners for increasing the activityof fungicides, to combinations of fungicides and safeners and to theiruse for controlling unwanted microorganisms.

Numerous triazole derivatives, strobilurins, aniline derivatives,dicarboximides, carboxamides and other chemical compounds are alreadyused for controlling unwanted microorganisms (see, for example, ThePesticide Manual, 13th Edition, Farnham, 2003).

However, since the environmental and economic requirements imposed onmodern-day fungicides are continually increasing, with regard, forexample, to the spectrum of action, toxicity, selectivity, applicationrate, formation of residues, and favourable preparability, and since,furthermore, there may be problems, for example, with resistances, aconstant task is to develop new fungicides which in some areas at leasthave advantages over their known counterparts.

Surprisingly, it has now been found that safeners, i.e. compounds whichimprove the compatibility of crop plants with herbicides, are suitablefor increasing the activity of fungicides against unwantedmicroorganisms, in particular phytopathogenic fungi.

This is even more surprising since generally safeners on their own haveno effect on the unwanted microorganisms.

Accordingly, the invention provides the use of compounds which improvethe compatibility of crop plants with herbicides (safeners) forincreasing the microbicidal, in particular fungicidal, activity offungicides.

The safener is generally a crop plant compatibility-improving compoundfrom the following group of compounds (group 1):

-   4-dichloroacetyl-1-oxa-4-azaspiro[4.5]decane (AD-67, MON-4660),    1-dichloroacetylhexahydro-3,3,8a-trimethylpyrrolo[1,2-a]pyrimidin-6(2H)-one    (dicyclonon, BAS-145138),    4-dichloroacetyl-3,4-dihydro-3-methyl-2H-1,4-benzoxazine    (benoxacor), 1-methylhexyl    5-chloroquinolin-8-oxyacetate(cloquintocet-mexyl—cf. also related    compounds in EP-A-0 086750, EP-A-0 094349, EP-A-0191736,    EP-A-0492366), 3-(2-chlorobenzyl)-1-(1-methyl-1-phenylethyl)urea    (cumyluron), α-(cyano-methoximino)phenylacetonitrile (cyometrinil),    2,4-dichlorophenoxyacetic acid (2,4-D),    4-(2,4-dichlorophenoxy)butyric acid (2,4-DB),    1-(1-methyl-1-phenylethyl)-3-(4-methylphenyl)urea (daimuron,    dymron), 3,6-dichloro-2-methoxybenzoic acid (dicamba),    S-1-methyl-1-phenylethyl piperidine-1-thiocarboxylate    (dimepiperate),    2,2-dichloro-N-(2-oxo-2-(2-propenylamino)ethyl)-N-(2-propenyl)acetamide    (DKA-24), 2,2-dichloro-N,N-di-2-propenylacetamide (dichlormid),    4,6-dichloro-2-phenylpyrimidine (fenclorim), ethyl    1-(2,4-dichlorophenyl)-5-trichloromethyl-1H-1,2,4-triazole-3-carboxylate    (fenchlorazole-ethyl—cf. also related compounds in EP-A-01174562 and    EP-A-346620), phenylmethyl 2-chloro    4-trifluoromethylthiazole-5-carboxylate (flurazole),    4-chloro-N-(1,3-dioxolan-2-ylmethoxy)-α-trifluoroacetophenone oxime    (fluxofenim), 3-dichloroacetyl-5-(2-furanyl)-2,2-dimethyloxazolidine    (furilazole, MON-13900), ethyl    4,5-dihydro-5,5-diphenyl-3-isoxazolecarboxylate    (isoxadifen-ethyl—cf. also related compounds in WO-A-95/07897),    1-(ethoxycarbonyl)ethyl 3,6-dichloro-2-methoxybenzoate    (lactidichlor), (4-chloro o-tolyloxy)acetic acid (MCPA),    2-(4-chloro-o-tolyloxy)propionic acid (mecoprop), diethyl    1-(2,4-dichlorophenyl)-4,5-dihydro-5-methyl-1H-pyrazole-3,5-dicarboxylate    (mefenpyr-diethyl—cf. also related compounds in WO-A-91/07874),    2-dichloromethyl-2-methyl-1,3-dioxolane (MG-191),    2-propenyl-1-oxa-4-azaspira[4.5]decane 4-carbodithioate (MG-838),    1,8-naphthalic anhydride,    α-(1,3-dioxolan-2-yl-methoximino)phenylacetonitrile (oxabetrinil),    2,2-dichloro-N-(1,3-dioxolan-2 ylmethyl)-N-(2-propenyl)acetamide    (PPG-1292), 3-dichloroacetyl-2,2-dimethyloxazolidine (R-28725),    3-dichloroacetyl-2,2,5-trimethyloxazolidine (R-29148),    4-(4-chloro-o-tolyl)butyric acid, 4-(4-chloro-phenoxy)butyric acid,    diphenylmethoxy acetic acid, methyl diphenylmethoxyacetate, ethyl    diphenylmethoxyacetate, methyl    1-(2-chlorophenyl)-5-phenyl-1H-pyrazole-3-carboxylate, ethyl    1-(2,4-dichlorophenyl)-5-methyl-1H-pyrazole-3-carboxylate, ethyl    1-(2,4-dichlorophenyl)-5-isopropyl-1H-pyrazole-3-carboxylate, ethyl    1-(2,4-dichlorophenyl)-5-(1,1-dimethylethyl)-1H-pyrazole-3-carboxylate,    ethyl 1-(2,4-dichlorophenyl)-5-phenyl-1H-pyrazole-3-carboxylate (cf.    also related compounds in EP-A-0269806 and EP-A-0333131), ethyl    5-(2,4-dichlorobenzyl)-2-isoxazoline-3-carboxylate, ethyl    5-phenyl-2-isoxazoline-3-carboxylate, ethyl    5-(4-fluorophenyl)-5-phenyl-2-isoxazoline-3-carboxylate (cf. also    related compounds in WO-A-91/08202), 1,3-dimethylbut-1-yl    5-chloroquinolin-8-oxyacetate, 4-allyloxybutyl    5-chloroquinolin-8-oxyacetate, 1-allyloxyprop-2-yl    5-chloroquinolin-8-oxyacetate, methyl    5-chloroquinoxalin-8-oxyacetate, ethyl    5-chloroquinolin-8-oxyacetate, allyl    5-chloroquinoxalin-8-oxyacetate, 2-oxoprop-1-yl    5-chloroquinolin-8-oxyacetate, diethyl    5-chloroquinolin-8-oxymalonate, diallyl    5-chloroquinoxalin-8-oxymalonate, diethyl    5-chloro-quinolin-8-oxymalonate (cf. also related compounds in    EP-A-0582198), 4-carboxychroman-4-yl-acetic acid (AC-304415, cf.    EP-A-0613618), 4-chlorophenoxyacetic acid,    3,3′-dimethyl-4-methoxybenzophenone,    1-bromo-4-chloromethylsulphonylbenzene,    1-[4-(N-2-methoxy-benzoylsulphamoyl)phenyl]-3-methylurea (alias    N-(2-methoxybenzoyl)-4-[(methylamino-carbonyl)amino]benzenesulphonamide),    1-[4-(N-2-methoxybenzoylsulphamoyl)phenyl]-3,3-dimethylurea,    1-[4-(N-4,5-dimethylbenzoylsulphamoyl)phenyl]-3-methylurea,    1-[4-(N-naphthyl-sulphamoyl)phenyl]-3,3-dimethylurea,    N-(2-methoxy-5-methylbenzoyl)-4-(cyclopropylamino-carbonyl)benzenesulphonamide,    and/or one of the following compounds of the general formulae (I-a),    (I-b), (I-c)

where

-   r represents a number 0, 1, 2, 3, 4 or 5,-   A¹ represents one of the divalent heterocyclic groupings shown below

-   s represents 0, 1, 2, 3, 4 or 5,-   A² represents optionally C₁-C₄-alkyl-, C₁-C₄-alkoxy-carbonyl- and/or    C₁-C₄-alkenyloxycarbonyl-substituted alkanediyl with 1 or 2 carbon    atoms,-   R¹ represents hydroxyl, mercapto, amino, C₁-C₆-alkoxy,    C₁-C₆-alkylthio, C₁-C₆-alkylamino or di(C₁-C₄-alkyl)amino,-   R² represents hydroxyl, mercapto, amino, C₁-C₇-alkoxy,    C₁-C₆-alkenyloxy, C₁-C₆-alkenyloxy-C₁-C₆-alkoxy, C₁-C₆-alkylthio,    C₁-C₆-alkylamino or di(C₁-C₄-alkyl)amino,-   R³ represents in each case optionally fluorine-, chlorine- and/or    bromine-substituted C₁-C₄-alkyl,-   R⁴ represents hydrogen, in each case optionally fluorine-, chlorine-    and/or bromine-substituted C₁-C₆-alkyl, C₂-C₆-alkenyl or    C₂-C₆-alkynyl, C₁-C₄-alkoxy-C₁-C₄-alkyl, dioxolanyl-C₁-C₄-alkyl,    furyl, furyl-C₁-C₄-alkyl, thienyl, thiazolyl, piperidinyl, or    optionally fluorine-, chlorine- and/or bromine- or    C₁-C₄-alkyl-substituted phenyl,-   R⁵ represents hydrogen, in each case optionally fluorine-, chlorine-    and/or bromine-substituted C₁-C₆-alkyl, C₂-C₆-alkenyl or    C₂-C₆-alkynyl, C₁-C₄-alkoxy-C₁-C₄-alkyl, dioxolanyl-C₁-C₄-alkyl,    furyl, furyl-C₁-C₄-alkyl, thienyl, thiazolyl, piperidinyl, or    optionally fluorine-, chlorine- and/or bromine- or    C₁-C₄-alkyl-substituted phenyl,-   R⁴ and R⁵ together also represent C₃-C₆-alkanediyl or    C₂-C₅-oxaalkanediyl, each of which is optionally substituted by    C₁-C₄-alkyl, phenyl, furyl, a fused-on benzene ring or by two    substituents which together with the C atom to which they are    attached form a 5- or 6-membered carbocycle,-   R⁶ represents hydrogen, cyano, halogen, or represents in each case    optionally fluorine-, chlorine- and/or bromine-substituted    C₁-C₄-alkyl, C₃-C₆-cycloalkyl or phenyl,-   R⁷ represents hydrogen, optionally hydroxyl-, cyano-, halogen- or    C₁-C₄-alkoxy-substituted C₁-C₆-alkyl, C₃-C₆-cycloalkyl or    tri(C₁-C₄-alkyl)silyl,-   R⁸ represents hydrogen, cyano, halogen, or represents in each case    optionally fluorine-, chlorine- and/or bromine-substituted    C₁-C₄-alkyl, C₃-C₆-cycloalkyl or phenyl,-   X¹ represents nitro, cyano, halogen, C₁-C₄-alkyl, C₁-C₄-haloalkyl,    C₁-C₄-alkoxy or C₁-C₄-haloalkoxy,-   X² represents hydrogen, cyano, nitro, halogen, C₁-C₄-alkyl,    C₁-C₄-haloalkyl, C₁-C₄-alkoxy or C₁-C₄-haloalkoxy,-   X³ represents hydrogen, cyano, nitro, halogen, C₁-C₄-alkyl,    C₁-C₄-haloalkyl, C₁-C₄-alkoxy or C₁-C₄-haloalkoxy,    and/or the following compounds of the general formulae (I-d), (I-e)

where

-   t represents 0, 1, 2, 3, 4 or 5,-   v represents 0, 1, 2, 3 or 4,-   R⁹ represents hydrogen or C₁-C₄-alkyl,-   R¹⁰ represents hydrogen or C₁-C₄-alkyl,-   R¹¹ represents hydrogen, in each case optionally cyano-, halogen- or    C₁-C₄-alkoxy-substituted C₁-C₆-alkyl, C₁-C₆-alkoxy, C₁-C₆-alkylthio,    C₁-C₆-alkylamino or di(C₁-C₄-alkyl)amino, or in each case optionally    cyano-, halogen- or C₁-C₄-alkyl-substituted C₃-C₆-cycloalkyl,    C₃-C₆-cycloalkyloxy, C₃-C₆-cycloalkylthio or C₃-C₆-cycloalkylamino,-   R¹² represents hydrogen, optionally cyano-, hydroxyl-, halogen- or    C₁-C₄-alkoxy-substituted C₁-C₆-alkyl, in each case optionally cyano-    or halogen-substituted C₃-C₆-alkenyl or C₃-C₆-alkynyl, or optionally    cyano-, halogen- or C₁-C₄-alkyl-substituted C₃-C₆-cycloalkyl,-   R¹³ represents hydrogen, optionally cyano-, hydroxyl-, halogen- or    C₁-C₄-alkoxy-substituted C₁-C₆-alkyl, in each case optionally cyano-    or halogen-substituted C₃-C₆-alkenyl or C₃-C₆-alkynyl, optionally    cyano-, halogen- or C₁-C₄-alkyl-substituted C₃-C₆-cycloalkyl, or    optionally nitro-, cyano-, halogen-, C₁-C₄-alkyl-, C₁-C₄-haloalkyl-,    C₁-C₄-alkoxy- or C₁-C₄-haloalkoxy-substituted phenyl, or together    with R¹⁹ represents in each case optionally C₁-C₄-alkyl-substituted    C₂-C₆-alkanediyl or C₂-C₅-oxaalkanediyl,-   X⁴ represents nitro, cyano, carboxyl, carbamoyl, formyl, sulphamoyl,    hydroxyl, amino, halogen, C₁-C₄-alkyl, C₁-C₄-haloalkyl, C₁-C₄-alkoxy    or C₁-C₄-haloalkoxy, and-   X⁵ represents nitro, cyano, carboxyl, carbamoyl, formyl, sulphamoyl,    hydroxyl, amino, halogen, C₁-C₄-alkyl, C₁-C₄-haloalkyl, C₁-C₄-alkoxy    or C₁-C₄-haloalkoxy.

In the definitions above and below, the saturated or unsaturatedhydrocarbon radicals, such as an alkyl, alkenyl or alkanediyl, are ineach case straight-chain or branched—including in combination withheteroatoms, such as an alkoxy.

Unless indicated otherwise, optionally substituted radicals may be mono-or polysubstituted, where in the case of polysubstitution thesubstituents may be identical or different.

The definition C₁-C₇-alkyl comprises the largest range defined here foran alkyl radical. Specifically, this definition comprises the meaningsmethyl, ethyl, n-, isopropyl, n-, iso-, sec-, tert-butyl, n-pentyl,1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1-ethylpropyl,1,1-dimethyl-propyl, 1,2-dimethylpropyl, 2,2-dimethylpropyl, and in eachcase all isomeric hexyls (such as, for example, n-hexyl, 1-methylpentyl,2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,2-dimethylbutyl,1,3-dimethylbutyl, 2,3-dimethylbutyl, 1,1-dimethylbutyl,2,2-dimethylbutyl, 3,3-dimethylbutyl, 1,1,2-trimethylpropyl,1,2,2-trimethylpropyl, 1-ethylbutyl, 2-ethylbutyl,1-ethyl-2-methylpropyl) and heptyls (such as, for example, n-heptyl,1-methylhexyl, 1-ethylpentyl, 2-ethylpentyl, 1-propylbutyl).

These definitions can also be applied to alkyl radicals in combinedmeanings, such as, for example, in alkoxy, alkylamine, haloalkyl orcycloalkylalkyl. The scope of definition is determined by the range ofcarbon atoms given in each case.

The definition C₂-C₆-alkenyl comprises the largest range defined herefor an alkenyl radical. Specifically, this definition comprises inparticular the meanings vinyl, 1-propenyl, 2-propenyl, 1-butenyl,2-butenyl, 3-butenyl, 1-methyl-4-propenyl, 2-methyl-1-propenyl,1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl,3-pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2-methyl-1-butenyl,3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl,3-methyl-2-butenyl, 1-methyl-3-butenyl, 2-methyl-3-butenyl,3-methyl-3-butenyl, 1,1-dimethyl-2-propenyl, 1,2-dimethyl-1-propenyl,1,2-dimethyl-2-propenyl, 1-ethyl-1-propenyl, 1-ethyl-2-propenyl,2-ethyl-2-propenyl, 1-propylvinyl, 1-hexenyl, 2-hexenyl, 3-hexenyl,4-hexenyl, 5-hexenyl, 1-methyl-1-pentenyl, 2-methyl-1-pentenyl,3-methyl-1-pentenyl, 4-methyl-1-pentenyl, 1-methyl-2-pentenyl,2-methyl-2-pentenyl, 3-methyl-2-pentenyl, 4-methyl-2-pentenyl,1-methyl-3-pentenyl, 2-methyl-3-pentenyl, 3-methyl-3-pentenyl,4-methyl-3-pentenyl, 1-methyl-4-pentenyl, 2-methyl-4-pentenyl,3-methyl-4-pentenyl, 4-methyl-4-pentenyl, 1,2-dimethyl-1-butenyl,1,3-dimethyl-1-butenyl, 1,2-dimethyl-1-butenyl, 2,3-dimethyl-1-butenyl,3,3-dimethyl-1-butenyl, 1-ethyl-1-butenyl, 2-ethyl-1-butenyl,1,1-dimethyl-2-butenyl, 1,2-dimethyl-2-butenyl, 1,3-dimethyl-2-butenyl,2,3-dimethyl-2-butenyl, 1-ethyl-2-butenyl, 2-ethyl-2-butenyl,1,1-dimethyl-3-butenyl, 1,2-dimethyl-3-butenyl, 1,3-dimethyl-3-butenyl,2,2-dimethyl-3-butenyl, 2,3-dimethyl-3-butenyl, 1-ethyl-3-butenyl,2-ethyl-3-butenyl, 1,1,2-trimethyl-2-propenyl,1-ethyl-1-methyl-2-propenyl and 1-ethyl-2-methyl-2-propenyl.

These definitions can also be applied to alkenyl radicals in thecombined meanings, such as, for example, in alkenyloxy or haloalkenyl.The scope of the definition is determined by the range of carbon atomsgiven in each case.

The definition C₂-C₆-alkynyl comprises the largest range defined herefor an alkynyl radical. Specifically, this definition comprises inparticular the meanings ethynyl, 1-propynyl, 2-propynyl, 1-butynyl,2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl,3-pentynyl, 4-pentynyl, 3-methyl-1-butynyl, 1-methyl-2-butynyl,1-methyl-3-butynyl, 2-methyl-3-butynyl, 1,1-dimethyl-2-propynyl,-ethyl-2-propynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl,5-hexynyl, 3-methyl-1-pentynyl, 4-methyl-1-pentynyl,1-methyl-2-pentynyl, 4-methyl-2-pentynyl, 1-methyl-3-pentynyl,2-methyl-3-pentynyl, 1-methyl-4-pentynyl, 2-methyl-4-pentynyl,3-methyl-4-pentynyl, 3,3-dimethyl-1-butynyl, 1,1-dimethyl-2-butynyl,1-ethyl-2-butynyl, 1,1-dimethyl-3-butynyl, 1,2-dimethyl-3-butynyl,2,2-dimethyl-3-butynyl, 1-ethyl-3-butynyl and 2-ethyl-3-butynyl.

These definitions can also be applied to alkynyl radicals in combinedmeanings, such as, for example, in alkynyloxy or haloalkynyl. The scopeof the definition is determined by a range of carbon atoms given in eachcase.

The definition C₃-C₆-cycloalkyl comprises the largest range defined herefor a cycloalkyl radical. Specifically, this definition comprises themeanings cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.

These definitions can also be applied to cycloalkyl radicals in combinedmeanings, such as, for example, in halocycloalkyl, cycloalkylamino orcycloalkylalkyl. The scope of the definition is determined by the rangeof carbon atoms given in each case.

Depending inter alia on the nature of the substituents, the compounds ofthe formulae (I-a), (I-b), (I-c), (I-d) and (I-e) can be present asgeometrical and/or optical isomers or isomer mixtures of varyingcomposition which, if appropriate, may be separated in a customarymanner. Both the pure isomers and the isomer mixtures can be used in thecompositions according to the invention and employed for the useaccording to the invention. However, hereinbelow, for the sake ofsimplicity, only compounds of the formulae (I-a), (I-b), (I-c), (I-d)and (I-e) are referred to, although what is meant are both the purecompounds and, if appropriate, any mixtures having varying proportionsof isomeric compounds.

Preferred meanings of the symbols and indices of the groups given informulae (I-a), (I-b), (I-c), (I-d) and (I-c) are defined below.

-   r preferably represents 0, 1, 2, 3 or 4,-   A¹ preferably represents one of the divalent heterocyclic groupings    shown below

-   s preferably represents 0, 1, 2, 3 or 4,-   A² preferably represents in each case optionally methyl-, ethyl-,    methoxycarbonyl-, ethoxycarbonyl- or allyloxycarbonyl-substituted    methylene or ethylene.-   R¹ preferably represents hydroxyl, mercapto, amino, methoxy, ethoxy,    n- or i-propoxy, n-, i-, s- or t-butoxy, methylthio, ethylthio, n-    or i-propylthio, n-, i-, s- or t-butylthio, methylamino, ethylamino,    n- or i-propylamino, n-, i-, s- or t-butylamino, dimethylamino or    diethylamino,-   R² preferably represents hydroxyl, mercapto, amino, methoxy, ethoxy,    n- or i-propoxy, n-, i-, s- or t-butoxy, 1-methylhexyloxy, allyloxy,    1-allyloxymethylethoxy, methylthio, ethylthio, n- or i-propylthio,    n-, i-, s- or t-butylthio, methylamino, ethylamino, n- or    i-propylamino, n-, i-, s- or t-butylamino, dimethylamino or    diethylamino,-   R³ preferably represents in each case optionally fluorine-,    chlorine- and/or bromine-substituted methyl, ethyl, n- or i-propyl,-   R⁴ preferably represents hydrogen, in each case optionally fluorine-    and/or chlorine-substituted methyl, ethyl, n- or i-propyl, n-, i-,    s- or t-butyl, propenyl, butenyl, propynyl or butynyl,    methoxymethyl, ethoxymethyl, methoxyethyl, ethoxyethyl,    dioxolanylmethyl, furyl, furylmethyl, thienyl, thiazolyl,    piperidinyl, or optionally fluorine-, chlorine-, methyl-, ethyl-, n-    or i-propyl-, n-, i-, s- or t-butyl-substituted phenyl,-   R⁵ preferably represents hydrogen, in each case optionally fluorine-    and/or chlorine-substituted methyl, ethyl, n- or i-propyl, n-, i-,    a- or t-butyl, propenyl, butenyl, propynyl or butynyl,    methoxymethyl, ethoxymethyl, methoxyethyl, ethoxyethyl,    dioxolanylmethyl, furyl, furylmethyl, thienyl, thiazolyl,    piperidinyl, or optionally fluorine-, chlorine-, methyl-, ethyl-, n-    or i-propyl-, n-, i-, s- or t-butyl-substituted phenyl, or together    with R represents one of the radicals —CH₂—O—CH₂—CH₂— and    —CH₂—CH₂—O—CH₂—CH₂—, which are optionally substituted by methyl,    ethyl, furyl, phenyl, a fused-on benzene ring or by two substituents    which together with the C atom to which they are attached form a 5-    or 6-membered carbocycle,-   R⁶ preferably represents hydrogen, cyano, fluorine, chlorine,    bromine, or represents in each case optionally fluorine-, chlorine-    and/or bromine-substituted methyl, ethyl, n- or i-propyl,    cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl or phenyl,-   R⁷ preferably represents hydrogen, optionally hydroxyl-, cyano-,    fluorine-, chlorine-, methoxy-, ethoxy-, n- or i-propoxy-substituted    methyl, ethyl, n- or i-propyl, n-, i-, s- or t-butyl,-   R⁸ preferably represents hydrogen, cyano, fluorine, chlorine,    bromine, or represents in each case optionally fluorine-, chlorine-    and/or bromine-substituted methyl, ethyl, n- or i-propyl, n-, i-, s-    or t-butyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl or    phenyl,-   X¹ preferably represents nitro, cyano, fluorine, chlorine, bromine,    methyl, ethyl, n- or i-propyl, n-, i-, a- or t-butyl,    difluoromethyl, dichloromethyl, trifluoromethyl, trichloromethyl,    chlorodifluoromethyl, fluorodichloromethyl, methoxy, ethoxy, n- or    i-propoxy, difluoromethoxy or trifluoromethoxy,-   X² preferably represents hydrogen, nitro, cyano, fluorine, chlorine,    bromine, methyl, ethyl, n- or i-propyl, n-, i-, s- or t-butyl,    difluoromethyl, dichloromethyl, trifluoromethyl, trichloromethyl,    chlorodifluoromethyl, fluorodichloromethyl, methoxy, ethoxy, n- or    i-propoxy, difluoromethoxy or trifluoromethoxy,-   X³ preferably represents hydrogen, nitro, cyano, fluorine, chlorine,    bromine, methyl, ethyl, n- or i-propyl, n-, i-, s- or t-butyl,    difluoromethyl, dichloromethyl, trifluoromethyl, trichloromethyl,    chlorodifluoromethyl, fluorodichloromethyl, methoxy, ethoxy, n- or    i-propoxy, difluoro-methoxy or trifluoromethoxy,-   t preferably represents the number 0, 1, 2, 3 or 4,-   v preferably represents the number 0, 1, 2 or 3,-   R⁹ preferably represents hydrogen, methyl, ethyl, n- or i-propyl,-   R¹⁰ preferably represents hydrogen, methyl, ethyl, n- or i-propyl,-   R¹¹ preferably represents hydrogen, in each case optionally cyano-,    fluorine-, chlorine-, methoxy-, ethoxy-, n- or i-propoxy-substituted    methyl, ethyl, n- or i-propyl, n-, i-, s- or t-butyl, methoxy,    ethoxy, n- or i-propoxy, n-, i-, s- or t-butoxy, methylthio,    ethylthio, n- or i-propylthio, n-, i-, s- or t-butylthio,    methylamino, ethylamino, n- or i-propylamino, n-, i-, a- or    t-butylamino, dimethylamino or diethylamino, or in each case    optionally cyano-, fluorine-, chlorine-, bromine-, methyl-, ethyl-,    n- or i-propyl-substituted cyclopropyl, cyclobutyl, cyclopentyl,    cyclohexyl, cyclopropyloxy, cyclobutyloxy, cyclopentyloxy,    cyclohexyloxy, cyclopropylthio, cyclobutylthio, cyclopentylthio,    cyclohexylthio, cyclopropylamino, cyclobutylamino, cyclopentylamino    or cyclohexylamino,-   R¹² preferably represents hydrogen, in each case optionally cyano-,    hydroxyl-, fluorine-, chlorine-, methoxy-, ethoxy-, n- or    i-propoxy-substituted methyl, ethyl, n- or i-propyl, n-, i- or    s-butyl, in each case optionally cyano-, fluorine-, chlorine- or    bromine-substituted propenyl, butenyl, propynyl or butynyl, or in    each case optionally cyano-, fluorine-, chlorine-, bromine-,    methyl-, ethyl-, n- or i-propyl-substituted cyclopropyl, cyclobutyl,    cyclopentyl or cyclohexyl,-   R¹³ preferably represents hydrogen, in each case optionally cyano-,    hydroxyl-, fluorine-, chlorine-, methoxy-, ethoxy-, n- or    i-propoxy-substituted methyl, ethyl, n- or i-propyl, n-, i- or    s-butyl, in each case optionally cyano-, fluorine-, chlorine- or    bromine-substituted propenyl, butenyl, propynyl or butynyl, in each    case optionally cyano-, fluorine-, chlorine-, bromine-, methyl-,    ethyl-, n- or i-propyl-substituted cyclopropyl, cyclobutyl,    cyclopentyl or cyclohexyl, or optionally nitro-, cyano-, fluorine-,    chlorine-, bromine-, methyl-, ethyl-, n- or i-propyl-, n-, i-, s- or    t-butyl-, trifluoromethyl-, methoxy-, ethoxy-, n- or i-propoxy-,    difluoromethoxy- or trifluoromethoxy-substituted phenyl, or together    with R¹² represents in each case optionally methyl- or    ethyl-substituted butane-1,4-diyl(trimethylene), pentane-1,5-diyl,    1-oxa-butane-1,4-diyl or 3-oxa-pentane-1,5-diyl,-   X⁴ preferably represents nitro, cyano, carboxyl, carbamoyl, formyl,    sulphamoyl, hydroxyl, amino, fluorine, chlorine, bromine, methyl,    ethyl, n- or i-propyl, n-, i-, s- or t-butyl, trifluoromethyl,    methoxy, ethoxy, n- or i-propoxy, difluoromethoxy or    trifluoromethoxy,-   X⁵ preferably represents nitro, cyano, carboxyl, carbamoyl, formyl,    sulphamoyl, hydroxyl, amino, fluorine, chlorine, bromine, methyl,    ethyl, n- or i-propyl, n-, i-, s- or t-butyl, trifluoromethyl,    methoxy, ethoxy, n- or i-propoxy, difluoromethoxy or    trifluoromethoxy.

Examples of compounds of the formula (I-a) which are very particularlypreferred as safeners according to the invention are listed in the tablebelow.

Specifically, particular mention may made of the following compounds ofthe formula (I-a):

TABLE 1 (I-a)

No. X¹ _(r) A¹ R¹ I-a-1 2-Cl, 4-Cl

OCH₃ I-a-2 2-Cl, 4-Cl

OCH₃ I-a-3 2-Cl, 4-Cl

OC₂H₅ I-a-4 2-Cl, 4-Cl

OC₂H₅ I-a-5 2-Cl

OCH₃ I-a-6 2-Cl, 4-Cl

OCH₃ I-a-7 2-F

OCH₃ I-a-8 2-F

OCH₃ I-a-9 2-Cl, 4-Cl

OC₂H₅ I-a-10 2-Cl, 4-CF₃

OCH₃ I-a-11 2-Cl

OCH₃ I-a-12 —

OC₂H₅ I-a-13 2-Cl, 4-Cl

OC₂H₅ I-a-14 2-Cl, 4-Cl

OC₂H₅ I-a-15 2-Cl, 4-Cl

OC₂H₅ I-a-16 2-Cl, 4-Cl

OC₂H₅ I-a-17 2-Cl, 4-Cl

OC₂H₅ I-a-18 —

OH

Specifically, particular mention may furthermore be made of thefollowing compounds of the formula (I-b):

TABLE 2 (I-b)

No. X² X³ A² R² I-b-1 5-Cl H CH₂ OH I-b-2 5-Cl H CH₂ OCH₃ I-b-3 5-Cl HCH₂ OC₂H₅ I-b-4 5-Cl H CH₂ OC₃H₇-n I-b-5 5-Cl H CH₂ OC₃H₇-i I-b-6 5-Cl HCH₂ OC₄H₉-n I-b-7 5-Cl H CH₂ OCH(CH₃)C₅H₁₁-n I-b-8 5-Cl 2-F CH₂ OH I-b-95-Cl 2-Cl CH₂ OH I-b-10 5-Cl H CH₂ OCH₂CH═CH₂ I-b-11 5-Cl H CH₂ OC₄H₉-iI-b-12 5-Cl H CH₂ OCH(CH₃)CH₂OCH₂CH═CH₂ I-b-13 5-Cl H

OCH₂CH═CH₂ I-b-14 5-Cl H

OC₂H₅ I-b-15 5-Cl H

OCH₃

Specifically, particular mention may furthermore be made of thefollowing compounds of the formula (I-c):

TABLE 3 (I-c)

No. R³ N(R⁴R⁵) IV-c-1 CHCl₂ N(CH₂CH═CH₂)₂ I-c-2 CHCl₂

I-c-3 CHCl₂

I-c-4 CHCl₂

I-c-5 CHCl₂

I-c-6 CHCl₂

I-c-7 CHCl₂

Specifically, particular mention may furthermore be made of thefollowing compounds of the formula (I-d):

TABLE 4 (I-d)

No. R⁹ R¹⁰ R¹¹ X⁴ _(t) X⁵ _(v) I-d-1 H H CH₃ 2-OCH₃ — I-d-2 H H C₂H₅2-OCH₃ — I-d-3 H H C₃H₇-n 2-OCH₃ — I-d-4 H H C₃H₇-i 2-OCH₃ — I-d-5 H H

2-OCH₃ — I-d-6 H H CH₃ 2-OCH₃, 5-CH₃ — I-d-7 H H C₂H₅ 2-OCH₃, 5-CH₃ —I-d-8 H H C₃H₇-n 2-OCH₃, 5-CH₃ — I-d-9 H H C₃H₇-i 2-OCH₃, 5-CH₃ — I-d-10H H

2-OCH₃, 5-CH₃ — I-d-11 H H OCH₃ 2-OCH₃, 5-CH₃ — I-d-12 H H OC₂H₅ 2-OCH₃,5-CH₃ — I-d-13 H H OC₃H₇-i 2-OCH₃, 5-CH₃ — I-d-14 H H SCH₃ 2-OCH₃, 5-CH₃— I-d-15 H H SC₂H₅ 2-OCH₃, 5-CH₃ — I-d-16 H H SC₃H₇-i 2-OCH₃, 5-CH₃ —I-d-17 H H NHCH₃ 2-OCH₃, 5-CH₃ — I-d-18 H H NHC₂H₅ 2-OCH₃, 5-CH₃ —I-d-19 H H NHC₃H₇-i 2-OCH₃, 5-CH₃ — I-d-20 H H

2-OCH₃, 5-CH₃ — I-4-21 H H NHCH₃ 2-OCH₃ — I-d-22 H H NHC₃H₇-i 2-OCH₃ —I-d-23 H H N(CH₃)₂ 2-OCH₃ — I-d-24 H H N(CH₃)₂ 3-CH₃, 4-CH₃ — I-d-25 H HCH₂—O—CH₃ 2-OCH₃ —

Specifically, particular mention may furthermore be made of thefollowing compounds of the formula (I-e):

TABLE 5 (I-e)

No. R⁹ R¹² R¹³ X⁴ _(t) X⁵ _(v) I-e-1 H H CH₃ 2-OCH₃ — I-e-2 H H C₂H₅2-OCH₃ — I-e-3 H H C₃H₇-n 2-OCH₃ — I-e-4 H H C₃H₇-i 2-OCH₃ — I-e-5 H H

2-OCH₃ — I-e-6 H CH₃ CH₃ 2-OCH₃ — I-e-7 H H CH₃ 2-OCH₃, 5-CH₃ — I-e-8 HH C₂H₅ 2-OCH₃, 5-CH₃ — I-e-9 H H C₃H₇-n 2-OCH₃, 5-CH₃ — I-e-10 H HC₃H₇-i 2-OCH₃, 5-CH₃ — I-e-11 H H

2-OCH₃, 5-CH₃ — I-e-12 H CH₃ CH₃ 2-OCH₃, 5-CH₃ —

Most preferred safeners of group 1 are cloquintocet-mexyl,fenchlorazol-ethyl, isoxadifen-ethyl, mefenpyr-diethyl, furilazole,fenclorim, cumyluron, dymron, dimepiperate and the compounds i-e-5 andi-e-11, and particular emphasis is given to cloquintocet-mexyl andmefenpyr-diethyl.

The compounds of the general formula (I-a) to be used as safeners areknown and/or can be prepared by processes known per se (cf. WO 91/07874,WO 95/07897).

The compounds of the general formula (I-b) to be used as safeners areknown and/or can be prepared by processes known per se (cf. EP-A 0 191736).

The compounds of the general formula (I-c) to be used as safeners areknown and/or can be prepared by processes known per se (cf. DE-A 22 18097, DE-A 23 50 547).

The compounds of the general formula (I-d) to be used as safeners areknown and/or can be prepared by processes known per se (cf. DE-A 196 21522, U.S. Pat. No. 6,235,680).

The compounds of the general formula (I-e) to be used as safeners areknown and/or can be prepared by processes known per se (cf. WO 99/66795,U.S. Pat. No. 6,251,827).

Further safeners mentioned in group 1 are described, for example, inC.D.S. Tomlin (Ed.), The Pesticide Manual, 13th Edition, British CropProtection Council, Farnham, 2003.

The fungicides used according to the invention are generally one or morecompounds from groups (2) to (24):

Group (2) Strobilurins of the General Formula (II)

in which

-   A³ represents one of the groups

-   A⁴ represents NH or O,-   A⁵ represents N or CH,-   L represents one of the groups

where the bond marked with an asterisk (*) is attached to the phenylring,

-   R¹⁴ represents phenyl, phenoxy or pyridinyl, each of which is    optionally mono- or disubstituted by identical or different    substituents from the group consisting of chlorine, cyano, methyl    and trifluoromethyl, or represents 1-(4-chlorophenyl)pyrazol-3-yl or    represents 1,2-propanedionebis(O-methyloxime)-1-yl,-   R¹⁵ represents hydrogen or fluorine;    Group (3) Triazoles of the General Formula (III)

in which

-   Q represents hydrogen or SH,-   m represents 0 or 1,-   R¹⁶ represents hydrogen, fluorine, chlorine, phenyl or    4-chlorophenoxy,-   R¹⁷ represents hydrogen or chlorine,-   A⁶ represents a direct bond, —CH₂—, —(CH₂)₂— or —O—,-   A⁶ furthermore represents *—CH₂—CHR²⁰— or *—CH═CR²⁰— where the bond    marked with * is attached to the phenyl ring, and-   R¹⁸ and R²⁰ furthermore together represent —CH₂—CH₂—CH[CH(CH₃)₂]— or    —CH₂—CH₂—C(CH₃)₂,-   A⁷ represents C or Si (silicon),-   A⁶ further represents —N(R²⁰)— and A⁷ furthermore together with R¹⁸    and R¹⁹ represents the groups C═N—R²¹, in which case R²⁰ and R²¹    together represent the group

where the bond marked with * is attached to R²⁰,

-   R¹⁸ represents hydrogen, hydroxyl or cyano,-   R¹⁹ represents 1-cyclopropylethyl, 1-chlorocyclopropyl, C₁-C₄-alkyl,    C₁-C₆-hydroxyalkyl, C₁-C₄-alkylcarbonyl,    C₁-C₂-haloalkoxy-C₁-C₂-alkyl, trimethylsilyl-C₁-C₂-alkyl,    monofluorophenyl or phenyl,-   R¹⁸ and R¹⁹ furthermore together represent —O—CH₂—CH(R²¹)—O—,    —O—CH₂—CH(R²¹)—CH₂— or —O—CH-(2-chlorophenyl)-,-   R²⁰ together with R¹⁸ represents —CH₂—CH₂—CH[CH(CH₃)₂]— or    —CH₂—CH₂—C(CH₃)₂—, or-   R²⁰ and R²¹ together represent the group

where the bond marked with * is attached to R²⁰,

-   R²¹ presents hydrogen, C₁-C₄-alkyl or bromine;    Group (4) Sulphenamides of the General Formula (IV)

in which R²² represents hydrogen or methyl;Group (5) Valinamides Selected from

-   (5-1) iprovalicarb-   (5-2)    N¹-[2-(4-{[3-(4-chlorophenyl)-2-propynyl]oxy}-3-methoxyphenyl)ethyl]-N²-(methylsulphonyl)-D-valinamide-   (5-3) benthiavalicarb    Group (6) Carboxamides of the General Formula (V)

in which

-   X⁶ represents 2-chloro-3-pyridinyl, represents 1-methylpyrazol-4-yl    which is substituted in the 3-position by methyl or trifluoromethyl    and in the 5-position by hydrogen or chlorine, represents    4-ethyl-2-ethylamino-1,3-thiazol-5-yl, represents    1-methylcyclohexyl, represents    2,2-dichloro-1-ethyl-3-methylcyclopropyl, represents    2-fluoro-2-propyl or represents phenyl which is mono- to    trisubstituted by identical or different substituents from the group    consisting of chlorine and methyl,-   X⁶ furthermore represents 3,4-dichloroisothiazol-5-yl,    5,6-dihydro-2-methyl-1,4-oxathiin-3-yl,    4-methyl-1,2,3-thiadiazol-5-yl,    4,5-dimethyl-2-trimethylsilylthiophen-3-yl, 1-methylpyrrol-3-yl    which is substituted in the 4-position by methyl or trifluoromethyl    and in the 5-position by hydrogen or chlorine,-   Y represents a direct bond, C₁-C₆-alkanediyl(alkylene) which is    optionally substituted by chlorine, cyano or oxo or represents    thiophenediyl,-   Y furthermore represents C₂-C₆-alkenediyl(alkenylene),-   Z represents hydrogen or the group

-   Z furthermore represents C₁-C₆-alkyl,-   A⁸ represents CH or N,-   R²³ represents hydrogen, chlorine, phenyl which is optionally mono-    or disubstituted by identical or different substituents from the    group consisting of chlorine and di(C₁-C₃-alkyl)aminocarbonyl,-   R²³ furthermore represents cyano or C₁-C₆-alkyl,-   R²⁴ represents hydrogen or chlorine,-   R²⁵ represents hydrogen, chlorine, hydroxyl, methyl or    trifluoromethyl,-   R²⁵ furthermore represents di(C₁-C₃-alkyl)aminocarbonyl,-   R²³ and R²⁴ furthermore together represent *—CH(CH₃)—CH₂—C(CH₃)₂— or    *—CH(CH₃)—O—C(CH₃)₂— where the bond marked with * is attached to    R²³;    Group (7) Dithiocarbamates Selected from-   (7-1) mancozeb-   (7-2) maneb-   (7-3) metiram-   (7-4) propineb-   (7-5) thiram-   (7-6) zineb-   (7-7) ziram    Group (8) Acyalanines of the General Formula (VI)

in which

-   * marks a carbon atom in the R or the S configuration, preferably in    the S configuration,-   R²⁶ represents benzyl, furyl or methoxymethyl;    Group (9): Anilinpyrimidines of the General Formula (VII)

in which

-   R²⁷ represents methyl, cyclopropyl or 1-propynyl;    Group (10): Benzimidazoles of the General Formula (VIII)

in which

-   R²⁸ and R²⁹ each represent hydrogen or together represent —O—CF₂—O—,-   R³⁶ represents hydrogen, C₁-C₄-alkylaminocarbonyl or    3,5-dimethylisoxazol-4-ylsulphonyl,-   R³⁹ represents chlorine, methoxycarbonylamino, chlorophenyl, furyl    or thiazolyl;    Group (11): Carbamates of the General Formula (IX)

in which

-   R³² represents n- or isopropyl.-   R³³ represents di(C₁-C₂-alkyl)amino-C₂-C₄-alkyl or diethoxyphenyl,    salts of these compounds also being included;    Group (12): Dicarboximides Selected from-   (12-1) captafol-   (12-2) captan-   (12-3) folpet-   (12-4) iprodione-   (12-5) procymidone-   (12-6) vinclozolin    Group (13): Guanidines Selected from-   (13-1) dodine-   (13-2) guazatine-   (13-3) iminoctadine triacetate-   (13-4) iminoctadine tris(albesilate)    Group (14): Imidazoles Selected from-   (14-1) cyazofamid-   (14-2) prochloraz-   (14-3) triazoxide-   (14-4) pefurazoate    Group (15): Morpholines of the General Formula (X)

in which

-   R³⁴ and R³⁵ independently of one another represent hydrogen or    methyl,-   R³⁶ represents C₁-C₁₄-alkyl (preferably C₁₂-C₁₄-alkyl),    C₅-C₁₂-cycloalkyl (preferably C₁₀-C₁₂-cycloalkyl),    phenyl-C₁-C₄-alkyl, which may be substituted in the phenyl moiety by    halogen or C₁-C₄-alkyl or represents acrylyl which is substituted by    chlorophenyl and dimethoxyphenyl;    Group (16): Pyrroles of the General Formula (XI)

in which

-   R³⁷ represents chlorine or cyano,-   R³⁸ represents chlorine or nitro,-   R³⁹ represents chlorine,-   R³⁸ and R³⁹ furthermore together represent —O—CF₂—O—;    Group (17): Phosphonates Selected from-   (17-1) fosetyl-Al-   (17-2) phosphonic acid;    Group (18): Phenylethanamides of the General Formula (XII)

in which

-   R⁴⁰ represents unsubstituted or fluorine-, chlorine-, bromine-,    methyl- or ethyl-substituted phenyl, 2-naphthyl,    1,2,3,4-tetrahydronaphthyl or indanyl;    Group (19): Fungicides Selected from-   (19-1) acibenzolar-S-methyl-   (19-2) chlorothalonil-   (19-3) cymoxanil-   (19-4) edifenphos-   (19-5) famoxadone-   (19-6) fluazinam-   (19-7) copper oxychloride-   (19-8) copper hydroxide-   (19-9) oxadixyl-   (19-10) spiroxamine-   (19-11) dithianon-   (19-12) metrafenone-   (19-13) fenamidone-   (19-14) 2,3-dibutyl-6-chlorothieno[2,3-d]pyrimidin-4(3H)-one-   (19-15) probenazole-   (19-16) isoprothiolane-   (19-17) kasugamycin-   (19-18) phthalide-   (19-19) ferimzone-   (19-20) tricyclazole-   (19-21)    N-({4-[(cyclopropylamino)carbonyl]phenyl}sulphonyl)-2-methoxybenzamide    Group (20): (Thio)urea Derivatives Selected from-   (20-1) pencycuron-   (20-2) thiophanate-methyl-   (20-3) thiohanate-ethyl    Group (21): Amides of the general formula (XIII)

in which

-   A⁹ represents a direct bond or —O—,-   A¹⁰ represents —C(═O)NH— or —NHC(═O)—,-   R⁴¹ represents hydrogen or C₁-C₄-alkyl,-   R⁴² represents C₁-C₆-alkyl;    Group (22): Triazolopyrimidines of the general formula (XIV)

in which

-   R⁴³ represents C₁-C₆-alkyl or C₂-C₆-alkenyl,-   R⁴⁴ represents C₁-C₆-alkyl,-   R⁴³ and R⁴⁴ furthermore together represent    C₁-C₆-alkanediyl(alkylene) which is mono- or disubstituted by    C₁-C₆-alkyl,-   R⁴⁵ represents bromine or chlorine,-   R⁴⁶ and R⁵⁰ independently of one another represent hydrogen,    fluorine, chlorine or methyl,-   R⁴⁷ and R⁴⁹ independently of one another represent hydrogen or    fluorine,-   R⁴⁸ represents hydrogen, fluorine or methyl,    Group (23): Iodochromones of the General Formula (XV)

in which

-   R⁵¹ represents C₁-C₆-alkyl,-   R⁵² represents C₁-C₆-alkyl, C₂-C₆-alkenyl or C₂-C₆-alkynyl;    Group (24): Biphenylcarboxamides of the General Formula (XVI)

in which

-   R⁵³ represents hydrogen or fluorine,-   R⁵¹ represents fluorine, chlorine, bromine, methyl, trifluoromethyl,    trifluoromethoxy, —CH═N—OMe or —C(Me)—N—OMe,-   R⁵⁵ represents hydrogen, fluorine, chlorine, bromine, methyl or    trifluoromethyl,-   Het represents one of the radicals Het1 to Het7 below:

-   R⁵⁶ represents iodine, methyl, difluoromethyl or trifluoromethyl,-   R⁵⁷ represents hydrogen, fluorine, chlorine or methyl,-   R⁵⁸ represents methyl, difluoromethyl or trifluoromethyl,-   R⁵⁹ represents chlorine, bromine, iodine, methyl, difluoromethyl or    trifluoromethyl,-   R⁶⁰ represents methyl or trifluoromethyl.

The formula (II) embraces the following preferred mixing partners ofgroup (2):

-   (2-1) azoxystrobin (known from EP-A 0 382 375) of the formula

-   (2-2) fluoxastrobin (known from DE-A 196 02 095) of the formula

-   (2-3)    (2E)-2-(2-{[6-(3-chloro-2-methylphenoxy)-5-fluoro-4-pyrimidinyl]oxy}phenyl)-2-(methoxy-imino)-N-methylethanamide    (known from DE-A 196 46 407, EP-B 0 712 396) of the formula

-   (2-4) trifloxystrobin (known from EP-A 0 460 575) of the formula

-   (2-5)    (2E)-2-(methoxyimino)-N-methyl-2-(2-{[({(1E)-1-[3-(trifluoromethyl)phenyl]ethylidene}-amino)oxy]methyl}phenyl)ethanamide    (known from EP-A 0 569 384) of the formula

-   (2-6)    (2E)-2-(methoxyimino)-N-methyl-2-{2-[(E)-({1-[3-(trifluoromethyl)phenyl)ethoxy}imino)-methyl]phenyl}ethanamide    (known from EP-A 0 596 254) of the formula

-   (2-7) orysastrobin (known from DE-A 195 39 324) of the formula

-   (2-8)    5-methoxy-2-methyl-4-(2-{[({(1E)-1-[3-(trifluoromethyl)phenyl]ethylidene}amino)oxy]-methyl}phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one    (known from WO 98/23155) of the formula

-   (2-9) kresoxim-methyl (known from EP-A 0 253 213) of the formula

-   (2-10) dimoxystrobin (known from EP-A 0 398 692) of the formula

-   (2-11) picoxystrobin (known from EP-A 0 278 595) of the formula

-   (2-12) pyraclostrobin (known from DE-A 44 23 612) of the formula

-   (2-13) metominostrobin (known from EP-A 0 398 692) of the formula

The formula (II) embraces the following preferred mixing partners ofgroup (3):

-   (3-1) azaconazole (known from DE-A 25 51 560) of the formula

-   (3-2) etaconazole (known from DE-A 25 51 560) of the formula

-   (3-3) propiconazole (known from DE-A 25 51 560) of the formula

-   (3-4) difenoconazole (known from EP-A 0 112 284) of the formula

-   (3-5) bromuconazole (known from EP-A 0 258 161) of the formula

-   (3-6) cyproconazole (known from DE-A 34 06 993) of the formula

-   (3-7) hexaconazole (known from DE-A 30 42 303) of the formula

-   (3-8) penconazole (known from DE-A 27 35 872) of the formula

-   (3-9) myclobutanil (known from EP-A 0 145 294) of the formula

-   (3-10) tetraconazole (known from EP-A 0 234 242) of the formula

-   (3-11) flutriafol (known from EP-A 0 015 756) of the formula

-   (3-12) epoxiconazole (known from EP-A 0 196 038) of the formula

-   (3-13) flusilazole (known from EP-A 0 068 813) of the formula

-   (3-14) simeconazole (known from EP-A 0 537 957) of the formula

-   (3-15) prothioconazole (known from WO 96/16048) of the formula

-   (3-16) fenbuconazole (known from DE-A 37 21 786) of the formula

-   (3-17) tebuconazole (known from EP-A 0 040 345) of the formula

-   (3-18) ipconazole (known from EP-A 0 329 397) of the formula

-   (3-19) metconazole (known from EP-A 0 329 397) of the formula

-   (3-20) triticonazole (known from EP-A 0 378 953) of the formula

-   (3-21) bitertanol (known from DE-A 23 24 010) of the formula

-   (3-22) triadimenol (known from DE-A 23 24 010) of the formula

-   (3-23) triadimefon (known from DE-A 22 01 063) of the formula

-   (3-24) fluquinconazole (known from EP-A 0 183 458) of the formula

-   (3-25) quinconazole (known from EP-A 0 183 458) of the formula

The formula (IV) embraces the following preferred mixing partners ofgroup (4):

-   (4-1) dichlofluanid (known from DE-A 11 93 498) of the formula

-   (4-2) tolylfluanid (known from DE-A 11 93 498) of the formula

Preferred mixing partners of group (5) are

-   (5-1) iprovalicarb (known from DE-A 40 26 966) of the formula

-   (5-3) benthiavalicarb (known from WO 96/04252) of the formula

The formula (V) embraces the following preferred mixing partners ofgroup (6):

-   (6-1) 2-chloro-N-(1,1,3-trimethylindan-4-yl)nicotinamide (known from    EP-A 0 256 503) of the formula

-   (6-2) boscalid (known from DE-A 195 31 813) of the formula

-   (6-3) furametpyr (known from EP-A 0 315 502) of the formula

-   (6-4)    N-(3-p-tolylthiophen-2-yl)-1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboxamide    (known from EP-A 0 737 682) of the formula

-   (6-5) ethaboxam (known from EP-A 0 639 574) of the formula

-   (6-6) fenhexamid (known from EP-A 0 339 418) of the formula

-   (6-7) carpropamid (known from EP-A 0 341 475) of the formula

-   (6-8)    2-chloro-4-(2-fluoro-2-methylpropionylamino)-N,N-dimethylbenzamide    (known from EP-A 0 600 629) of the formula

-   (6-9) picobenzamid (known from WO 99/42447) of the formula

-   (6-10) zoxamide (known from EP-A 0 604 019) of the formula

-   (6-11) 3,4-dichloro-N-(2-cyanophenyl)isothiazole-5-carboxamide    (known from WO 99/24413) of the formula

-   (6-12) carboxin (known from U.S. Pat. No. 3,249,499) of the formula

-   (6-13) tiadinil (known from U.S. Pat. No. 6,616,054) of the formula

-   (6-14) penthiopyrad (known from EP-A 0 737 682) of the formula

-   (6-15) silthiofam (known from WO 96/18631) of the formula

-   (6-16)    N-[2-(1,3-dimethylbutyl)phenyl]-1-methyl-4-(trifluoroethyl)-1H-pyrrole-3-carboxamide    (known from WO 02/38542) of the formula

Preferred mixing partners of group (7) are

-   (7-1) mancozeb (known from DE-A 12 34 704) having the IUPAC name    manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc    salt-   (7-2) maneb (known from U.S. Pat. No. 2,504,404) of the formula

-   (7-3) metiram (known from DE-A 10 76 434) having the IUPAC name zinc    ammoniate ethylenebis(dithiocarbamate)-poly(ethylenethiuram    disulphide)-   (7-4) propineb (known from GB 935 981) of the formula

-   (7-5) thiram (known from U.S. Pat. No. 1,972,961) of the formula

-   (7-6) zineb (known from DE-A 10 81 446) of the formula

-   (7-7) ziram (known from U.S. Pat. No. 2,588,428) of the formula

The formula (VI) embraces the following preferred mixing partners ofgroup (8):

-   (8-1) benalaxyl (known from DE-A 29 03 612) of the formula

-   (8-2) furalaxyl (known from DE-A 25 13 732) of the formula

-   (8-3) metalaxyl (known from DE-A 25 15 091) of the formula

-   (8-4) metalaxyl-M (known from WO 96/01559) of the formula

-   (8-5) benalaxyl-M of the formula

The formula (VII) embraces the following preferred mixing partners ofgroup (9):

-   (9-1) cyprodinil (known from EP-A 0 310 550) of the formula

-   (9-2) mepanipyrim (known from EP-A 0 270 111) of the formula

-   (9-3) pyrimethanil (known from DD 151 404) of the formula

The formula (VIII) embraces the following preferred mixing partners ofgroup (10):

-   (10-1)    6-chloro-5-[(3,5-dimethylisoxazol-4yl)sulphonyl]-2,2-difluoro-5H-[1,3]dioxolo[4,5-f]-benzimidazole    (known from WO 97/06171) of the formula

-   (10-2) benomyl (known from U.S. Pat. No. 3,631,176) of the formula

-   (10-3) carbendazim (known from U.S. Pat. No. 3,010,968) of the    formula

-   (10-4) chlorfenazole of the formula

-   (10-5) fuberidazole (known from DE-A 12 09 799) of the formula

-   (10-6) thiabendazole (known from U.S. Pat. No. 3,206,468) of the    formula

The formula (IX) embraces the following preferred mixing partners ofgroup (11):

-   (11-1) diethofencarb (known from EP-A 0 078 663) of the formula

-   (11-2) propamocarb (known from U.S. Pat. No. 3,513,241) of the    formula

-   (11-3) propamocarb-hydrochloride (known from U.S. Pat. No.    3,513,241) of the formula

-   (11-4) propamocarb-fosetyl of the formula

Preferred mixing partners of group (12) are

-   (12-1) captafol (known from U.S. Pat. No. 3,178,447) of the formula

-   (12-2) captan (known from U.S. Pat. No. 2,553,770) of the formula

-   (12-3) folpet (known from U.S. Pat. No. 2,553,770) of the formula

-   (12-4) iprodione (known from DE-A 21 49 923) of the formula

-   (12-5) procymidone (known from DE-A 20 12 656) of the formula

-   (12-6) vinclozolin (known from DE-A 22 07 576) of the formula

Preferred mixing partners of group (13) are

-   (13-1) dodine (known from GB 11 03 989) of the formula

-   (13-2) guazatine (known from GB 11 14 155)-   (13-3) iminoctadine triacetate (known from EP-A 0 155 509) of the    formula

Preferred mixing partner of the group (14) are

-   (14-1) cyazofamid (known from EP-A 0 298 196) of the formula

-   (14-2) prochloraz (known from DE-A 24 29 523) of the formula

-   (14-3) triazoxide (known from DE-A 28 02 488) of the formula

-   (14-4) pefurazoate (known from EP-A 0 248 086) of the formula

The formula (X) embraces the following preferred mixing partners ofgroup (15):

-   (15-1) aldimorph (known from DD 140 041) of the formula

-   (15-2) tridemorph (known from GB 988 630) of the formula

-   (15-3) dodemorph (known from DE-A 25 432 79) of the formula

-   (15-4) fenpropimorph (known from DE-A 26 56 747) of the formula

-   (15-5) dimethomorph (known from EP-A 0 219 756) of the formula

The formula (XI) embraces the following preferred mixing partners ofgroup (16):

-   (16-1) fenpiclonil (known from EP-A 0 236 272) of the formula

-   (16-2) fludioxonil (known from EP-A 0 206 999) of the formula

-   (16-3) pyrrolnitrin (known from JP 65-25876) of the formula

Preferred mixing partners of group (17) are

-   (17-1) fosetyl-Al (known from DE-A 24 56 627) of the formula

-   (17-2) phosphonic acid (known chemical) of the formula

The formula (XII) embraces the following preferred mixing partners ofgroup (18) which are known from WO 96/23793 and can in each case bepresent as E or Z isomers. Accordingly, compounds of the formula (XII)can be present as a mixture of different isomers or else in the form ofa single isomer. Preference is given to compounds of the formula (XII)in the form of their E isomers:

-   (18-1) the compound    2-(2,3-dihydro-1H-inden-5-yl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(methoxy-imino)acetamide    of the formula

-   (18-2) the compound    N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(methoxyimino)-2-(5,6,7,8-tetrahydro-naphthalen-2-yl)acetamide    of the formula

-   (18-3) the compound    2-(4-chlorophenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(methoxyimino)-acetamide    of the formula

-   (18-4) the compound    2-(4-bromophenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(methoxyimino)-acetamide    of the formula

-   (18-5) the compound    2-(4-methylphenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(methoxyimino)-acetamide    of the formula

-   (18-6) the compound    2-(4-ethylphenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(methoxyimino)-acetamide    of the formula

Preferred mixing partners of group (19) are

-   (19-1) acibenzolar-S-methyl (known from EP-A 0 313 512) of the    formula

-   (19-2) chlorothalonil (known from U.S. Pat. No. 3,290,353) of the    formula

-   (19-3) cymoxanil (known from DE-A 23 12 956) of the formula

-   (19-4) edifenphos (known from DE-A 14 93 736) of the formula

-   (19-5) famoxadone (known from EP-A 0 393 911) of the formula

-   (19-6) fluazinam (known from EP-A 0 031257) of the formula

-   (19-7) copper oxychloride-   (19-9) oxadixyl (known from DE-A 30 30 026) of the formula

-   (19-10) spiroxamine (known from DE-A 37 35 555) of the formula

-   (19-11) dithianon (known from JP-A 44-29464) of the formula

-   (19-12) metrafenone (known from EP-A 0 897 904) of the formula

-   (19-13) fenamidone (known from EP-A 0 629 616) of the formula

-   (19-14) 2,3-dibutyl-6-chlorothieno[2,3-d]pyrimidin-4(3H)one (known    from WO 99/14202) of the formula

-   (19-15) probenazole (known from U.S. Pat. No. 3,629,428) of the    formula

-   (19-16) isoprothiolane (known from U.S. Pat. No. 3,856,814) of the    formula

-   (19-17) kasugamycin (known from GB 1094 567) of the formula

-   (19-18) phthalide (known from JP-A 57-55844) of the formula

-   (19-19) ferimzone (known from EP-A 0 019 450) of the formula

-   (19-20) tricyclazole (known from DE-A 22 50 077) of the formula

-   (19-21)    N-({4-[(cyclopropylamino)carbonyl]phenyl}sulphonyl)-2-methoxybenzamide    of the formula

Preferred mixing partners of group (20) are

-   (20-1) pencycuron (known from DB-A 27 32 257) of the formula

-   (20-2) thiophanate-methyl (known from DE-A 18 06 123) of the formula

-   (20-3) thiophanate-ethyl (known from DE-A 18 06 123) of the formula

Preferred mixing partners of group (21) are

-   (21-1) fenoxanil (known from EP-A 0 262 393) of the formula

-   (21-2) dicylcomat (known from JP-A 7-206608) of the formula

Preferred mixing partners of group (22) are

-   (22-1)    5-chloro-N-[(1S)-2,2,2-trifluoro-1-methylethyl]-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo-[1,5-a]pyrimidine-7-amine    (known from U.S. Pat. No. 5,986,135) of the formula

-   (22-2)    5-chloro-N-[(1R)-1,2-dimethylpropyl]-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[1,5-a]-pyrimidine-7-amine    (known from WO 02/38565) of the formula

-   (22-3)    5-chloro-6-(2-chloro-6-fluorophenyl)-7-(4-methylpiperidin-1-yl)[1,2,4]triazolo[1,5-a]-pyrimidine    (known from U.S. Pat. No. 5,593,996) of the formula

Preferred mixing partners of group (23) are

-   (23-1) 2-butoxy-6-iodo-3-propylbenzopyran-4-one (known from WO    03/014103) of the formula

-   (23-2) 2-ethoxy-6-iodo-3-propylbenzopyran-4-one (known from WO    03/014103) of the formula

-   (23-3) 6-iodo-2-propoxy-3-propylbenzopyran-4-one (known from WO    03/014103) of the formula

-   (23-4) 2-but-2-ynyloxy-6-iodo-3-propylbenzopyran-4-one (known from    WO 03/014103) of the formula

-   (23-5) 6-iodo-2-(1-methylbutoxy)-3-propylbenzopyran-4-one (known    from WO 03/014103) of the formula

-   (23-6) 2-but-3-enyloxy-6-iodobenzopyran-4-one (known from WO    03/014103) of the formula

-   (23-7) 3-butyl-6-iodo-2-isopropoxybenzopyran-4-one (known from WO    03/014103) of the formula

Preferred mixing partners of group (24) are

-   (24-1)    N-(3′,4′-dichloro-5-fluoro-1,1′-biphenyl-2-yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide    (known from WO 03/070705) of the formula

-   (24-2)    3-(difluoromethyl)-N-{3′-fluoro-4′-[(E)-(methoxyimino)methyl]-1,1′-biphenyl-2-yl}-methyl-1H-pyrazole-4-carboxamide    (known from WO 02/08197) of the formula

-   (24-3)    3-(trifluoromethyl)-N-{3′-fluoro-4′-[(E)-(methoxyimino)methyl]-1,1′-biphenyl-2-yl}-1-methyl-1H-pyrazole-4-carboxamide    (known from WO 02/08197) of the formula

-   (24-4)    N-(3′,4′-dichloro-1,1′-biphenyl-2-yl)-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide    (known from WO 00/14701) of the formula

-   (24-5)    N-(4′-chloro-3′-fluoro-1,1′-biphenyl-2-yl)-2-methyl-4-trifluoromethyl)-1,3-thiazole-5-carboxamide    (known from WO 03/066609) of the formula

-   (24-6)    N-(4′-chloro-1,1′-biphenyl-2-yl)-4-(difluoromethyl)-2-methyl-1,3-thiazole-5-carboxamide    (known from WO 03/066610) of the formula

-   (24-7)    N-(4′-bromo-1,1′-biphenyl-2-yl)-4-(difluoromethyl)-2-methyl-1,3-thiazole-5-carboxamide    (known from WO 03/066610) of the formula

-   (24-8)    4-(difluoromethyl)-2-methyl-N-[4′-(trifluoromethyl)-1,1′-biphenyl-2-yl]-1,3-thiazole-5-carboxamide    (known from WO 03/066610) of the formula

Compound (6-7), carpropamid, has three asymmetrically substituted carbonatoms. Accordingly, compound (6-7) can be present as a mixture ofdifferent isomers or else in the form of a single component. Particularpreference is given to the compounds

(1S,3R)-2,2-dichloro-N-[(1R)-1-(4-chlorophenyl)ethyl]-1-ethyl-3-methylcyclopropanecarboxamideof the formula

and

(1R,3S)-2,2-dichloro-N-[(1R)-1-(4-chlorophenyl)ethyl]-1-ethyl-3-methylcyclopropanecarboxamideof the formula

The following fungicidal active compounds are particularly preferred:

-   (2-1) azoxystrobin-   (2-2) fluoxastrobin-   (2-3)    (2E)-2-(2-{[6-(3-chloro-2-methylphenoxy)-5-fluoro-4-pyrimidinyl]oxy}phenyl)-2-(methoxyimino)-N-methylethanamide-   (2-4) trifloxystrobin-   (2-5)    (2E)-2-(methoxyimino)-N-methyl-2-(2-{[({(1E)-1-[3-(trifluoromethyl)-phenyl]ethylidene}amino)oxy]methyl}phenyl)ethanamide-   (2-6)    (2E)-2-(methoxyimino)-N-methyl-2-{2-[(E)-({1-[3-(trifluoromethyl)phenyl]-ethoxy}imino)methyl]phenyl}ethanamide-   (2-8)    5-methoxy-2-methyl-4-(2-{[({(1E)-1-[3-(trifluoromethyl)phenyl]ethylidene}-amino)oxy]methyl}phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one-   (2-9) kresoxim-methyl-   (2-10) dimoxystrobin-   (2-11) picoxystrobin-   (2-12) pyraclostrobin-   (2-13) metominostrobin-   (3-3) propiconazole-   (3-4) difenoconazole-   (3-6) cyproconazole-   (3-7) hexaconazole-   (3-8) penconazole-   (3-9) myclobutanil-   (3-10) tetraconazole-   (3-13) flusilazole-   (3-15) prothioconazole-   (3-16) fenbuconazole-   (3-17) tebuconazole-   (3-21) bitertanol-   (3-22) triadimenol-   (3-23) triadimefon-   (3-12) epoxiconazole-   (3-19) metconazole-   (3-24) fluquinconazole-   (4-1) dichlofluanid-   (4-2) tolylfluanid-   (5-1) iprovalicarb-   (5-3) benthiavalicarb-   (6-2) boscalid-   (6-5) ethaboxam-   (6-6) fenhexamid-   (6-7) carpropamid-   (6-8)    2-chloro-4-[(2-fluoro-2-methylpropenoyl)amino]-N,N-dimethylbenzamide-   (6-9) picobenzamid-   (6-10) zoxamide-   (6-11) 3,4-dichloro-N-(2-cyanophenyl)isothiazole-5-carboxamide-   (6-14) penthiopyrad-   (6-16)    N-[2-(1,3-dimethylbutyl)phenyl]-1-methyl-4-(trifluoromethyl)-1H-pyrrole-3-carboxamide-   (7-1) mancozeb-   (7-2) maneb-   (7-4) propineb-   (7-5) thiram-   (7-6) zineb-   (8-1) benalaxyl-   (8-2) furalaxyl-   (8-3) metalaxyl-   (8-4) metalaxyl-M-   (8-5) benalaxyl-M-   (9-1) cyprodinil-   (9-2) mepanipyrim-   (9-3) pyrimethanil-   (10-1)    6-chloro-5-[(3,5-dimethylisoxazol-4-yl)sulphonyl]-2,2-difluoro-5H-[1,3]dioxolo[4,5-f]-benzimidazole-   (10-3) carbendazim-   (11-1) diethofencarb-   (11-2) propamocarb-   (11-3) propamocarb-hydrochloride-   (11-4) propamocarb-fosetyl-   (12-2) captan-   (12-3) folpet-   (12-4) iprodione-   (12-5) procymidone-   (13-1) dodine-   (13-2) guazatine-   (13-3) iminoctadine triacetate-   (14-1) cyazofamid-   (14-2) prochloraz-   (14-3) triazoxide-   (15-5) dimethomorph-   (15-4) fenpropimorph-   (16-2) fludioxonil-   (17-1) fosetyl-Al-   (17-2) phosphonic acid-   (19-1) acibenzolar-S-methyl-   (19-2) chlorothalonil-   (19-3) cymoxanil-   (19-5) famoxadone-   (19-7) copper oxychloride-   (19-6) fluazinam-   (19-9) oxadixyl-   (19-10) spiroxamine-   (19-13) fenamidone-   (20-1) pencycuron-   (20-2) thiophanate-methyl-   (22-1)    5-chloro-N-[(1S)-2,2,2-trifluo-1-methylethyl]-6-(2,4,6-trifluorophenyl)[1,2,4]-triazolo[1,5-a]pyrimidine-7-amine-   (22-2)    5-chloro-N-[(1R)-1,2-dimethylpropyl]-6-(2,4,6-trifluorophenyl)[1,4]triazolo[1,5-a]-pyrimidine-7-amine-   (23-1) 2-butoxy-6-iodo-3-propylbenzopyran-4-one-   (23-2) 2-ethoxy-6-iodo-3-propylbenzopyran-4-one-   (23-3) 6-iodo-2-propoxy-3-propylbenzopyran-4-one-   (24-1)    N-(3′,4′-dichloro-5-fluoro-1,1′-biphenyl-2-yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide-   (24-3)    3-(trifluoromethyl)-N-{(3′-fluoro-4′-[(E)-(methoxyimino)methyl]-1,1′-biphenyl-2-yl}-1-methyl-1H-pyrazole-4-carboxamide-   (24-7)    N-(4′-bromo-1,1′-biphenyl-2-yl)-4-(difluoromethyl)-2-methyl-1,3-thiazole-5-carboxamide

Very particularly preferred mixing partners are the following activecompounds:

-   (2-2) fluoxastrobin-   (2-3)    (2E)-2-(2-{[6-(3-chloro-2-methylphenoxy)-5-fluoro-4-pyrimidinyl]oxy}phenyl)-2-(methoxyimino)-N-methylethanamide-   (2-4) trifloxystrobin-   (3-15) prothioconazole-   (3-17) tebuconazole-   (3-21) bitertanol-   (3-22) triadimenol-   (3-24) fluquinconazole-   (4-1) dichlofluanid-   (4-2) tolylfluanid-   (5-1) iprovalicarb-   (6-6) fenhexamid-   (6-7) carpropamid-   (6-9) picobenzamid-   (6-14) penthiopyrad-   (7-4) propineb-   (8-4) metalaxyl-M-   (8-5) benalaxyl-M-   (9-3) pyrimethanil-   (10-3) carbendazim-   (11-4) propamocarb-fosetyl-   (12-4) iprodione-   (14-2) prochloraz-   (14-3) triazoxide-   (16-2) fludioxonil-   (19-10) spiroxamine-   (24-1)    N-(3′,4′-dichloro-5-fluoro-1,1′-biphenyl-2-yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide

Preference is given to safener/fungicide combinations used according tothe invention comprising a preferred compound of group 1 and a preferredcompound of groups 2 to 24.

Particular preference is given to safener/fungicide combinations usedaccording to the invention comprising a particularly preferred compoundof group 1 and a particularly preferred compound of groups 2 to 24.

Very particular preference is given to safener/fungicide combinationsused according to the invention comprising a very particularly preferredcompound of group 1 and a very particularly preferred compound of groups2 to 24.

Especially preferred are the safener/fungicide combinations listedbelow.

-   1. Combinations of cloquintocet-mexyl (S1) with particularly    preferred fungicidally active compounds of groups 2 to 24:    -   (S1)/(2-1), (S1)/(2-2), (S1)/(2-3), (S1)/(2-4), (S1)/(2-5),        (S1)/(2-6), (S1)/(2-8), (S1)/(2-9), (S1)/(2-10), (S1)/(2-11),        (S1)/(2-12), (S1)/(2-13);    -   (S1)/(3-3), (S1)/(3-4), (S1)/(3-6), (S1)/(3-7), (S1)/(3-8),        (S1)/(3-9), (S1)/(3-10), (S1)/(3-12), (S1)/(3-13), (S1)/(3-S15),        (S1)/(3-16), (S1)/(3-17), (S1)/(3-19), (S1)/(3-21), (S1)/(3-22),    -   (S1)/(3-23), (S1)/(3-24);    -   (S1)/(4-1), (S1)/(4-2);    -   (S1)/(5-1), (S1)/(5-3);    -   (S1)/(6-2), (S1)/(6-5), (S1)/(6-6), (S1)/(6-7), (S1)/(6-8),        (S1)/(6-9), (S1)/(6-10), (S1)/(6-11), (S1)/(6-14), (S1)/(6-16);    -   (S1)/(7-1), (S1)/(7-2), (S1)/(7-4), (S1)/(7-5), (S1)/(7-6);    -   (S1)/(8-1), (S1)/(8-2), (S1)/(8-3), (S1)/(8-4), (S1)/(8-5);    -   (S1)/(9-1), (S1)/(9-2), (S1)/(9-3);    -   (S1)/(10-1), (S1)/(10-3);    -   (S1)/(11-1), (S1)/(11-2), (S1)/(11-3), (S1)/(11-4);    -   (S1)/(12-2), (S1)/(12-3), (S1)/(12-4), (S1)/(12-5);    -   (S1)/(13-1), (S1)/(13-2), (S1)/(13-3);    -   (S1)/(14-1), (S1)/(14-2), (S1)/(14-3);    -   (S1)/(15-4), (S1)/(15-5);    -   (S1)/(16-2);    -   (S1)/(17-1), (S1)/(17-2);    -   (S1)/(19-1), (S1)/(19-2), (S1)/(19-3), (S1)/(19-5), (S1)/(19-6),        (S1)/(19-7), (S1)/(19-9), (S1)/(19-10), (S1)/(19-13);    -   (S1)/(20-1), (S1)/(20-2);    -   (S1)/(22-1), (S1)/(22-2);    -   (S1)/(23-1), (S1)/(23-2), (S1)/(23-3);    -   (S1)/(24-1), (S1)/(24-3), (S1)/(24-7);-   2. Combinations of fenchlorazole-ethyl (S2) with particularly    preferred fungicidally active compounds of groups 2 to 24:    -   (S2)/(2-1), (S2)/(2-2), (S2)/(2-3), (S2)/(2-4), (S2)/(2-5),        (S2)/(2-6), (S2)/(2-8), (S2)/(2-9), (S2)/(2-10), (S2)/(2-11),        (S2)/(2-12), (S2)/(2-13);    -   (S2)/(3-3), (S2)/(3-4), (S2)/(3-6), (S2)/(3-7), (S2)/(3-8),        (S2)/(3-9), (S2)/(3-10), (S2)/(3-12), (S2)/(3-13), (S2)/(3-15),        (S2)/(3-16), (S2)/(3-1 7), (S2)/(3-19), (S2)/(3-21),        (S2)/(3-22),    -   (S2)/(3-23), (S2)/(3-24);    -   (S2)/(4-1), (S2)/(4-2);    -   (S2)/(5-1), (S2)/(5-3);    -   (S2)/(6-2), (S2)/(6-5), (S2)/(6-6), (S2)/(6-7), (S2)/(6-8),        (S2)/(6-9), (S2)/(6-10), (S2)/(6-11), (S2)/(6-14), (S2)/(6-16);    -   (S2)/(7-1), (S2)/(7-2), (S2)/(7-4), (S2)/(7-5), (S2)/(7-6);    -   (S2)/(8-1), (S2)/(8-2), (S2)/(8-3), (S2)/(8-4), (S2)/(8-5);    -   (S2)/(9-1), (S2)/(9-2), (S2)/(9-3);    -   (S2)/(10-1), (S2)/(10-3);    -   (S2)/(11-1), (S2)/(11-2), (S2)/(11-3), (S2)/(11-4);    -   (S2)/(12-2), (S2)/(12-3), (S2)/(12-4), (S2)/(12-5);    -   (S2)/(13-1), (S2)/(13-2), (S2)/(13-3);    -   (S2)/(14-1), (S2)/(14-2), (S2)/(14-3);    -   (S2)/(15-4), (S2)/(15-5);    -   (S2)/(16-2);    -   (S2)/(1 7-1), (S2)/(17-2);    -   (S2)/(19-1), (S2)/(19-2), (S2)/(19-3), (S2)/(19-5), (S2)/(19-6),        (S2)/(19-7), (S2)/(19-9), (S2)/(19-10), (S2)/(19-13);    -   (S2)/(20-1), (S2)/(20-2);    -   (S2)/(22-1), (S2)/(22-2);    -   (S2)/(23-1), (S2)/(23-2), (S2)/(23-3);    -   (S2)/(24-1), (S2)/(24-3), (S1)/(24-7);-   3. Combinations of isoxadifen-ethyl (S3) with particularly preferred    fungicidally active compounds of groups 2 to 24:    -   (S3)/(2-1), (S3)/(2-2), (S3)/(2-3), (S3)/(2-4), (S3)/(2-5),        (S3)/(2-6), (S3)/(2-8), (S3)/(2-9), (S3)/(2-10), (S3)/(2-11),        (S3)/(2-12), (S3)/(2-13);    -   (S3)/(3-3), (S3)/(3-4), (S3)/(3-6), (S3)/(3-7), (S3)/(3-8),        (S3)/(3-9), (S3)/(3-10), (S3)/(3-12), (S3)/(3-13), (S3)/(3-15),        (S3)/(3-16), (S3)/(3-17), (S3)/(3-19), (S3)/(3-21), (S3)/(3-22),        (S3)/(3-23), (S3)/(3-24);    -   (S3)/(4-1), (S3)/(4-2);    -   (S3)/(5-1), (S3)/(5-3);    -   (S3)/(6-2), (S3)/(6-5), (S3)/(6-6), (S3)/(6-7), (S3)/(6-8),        (S3)/(6-9), (S3)/(6-10), (S3)/(6-11), (S3)/(6-14), (S3)/(6-16);    -   (S3)/(7-1), (S3)/(7-2), (S3)/(7-4), (S3)/(7-5), (S3)/(7-6);    -   (S3)/(8-1), (S3)/(8-2), (S3)/(8-3), (S3)/(8-4), (S3)/(8-5);    -   (S3)/(9-1), (S3)/(9-2), (S3)/(9-3);    -   (S3)/(10-1), (S3)/(10-3);    -   (S3)/(11-1), (S3)/(11-2), (S3)/(11-3), (53)/(11-4);    -   (S3)/(12-2), (S3)/(12-3), (S3)/(12-4), (S3)/(12-5);    -   (S3)/(13-1), (S3)/(13-2), (S3)/(13-3);    -   (S3)/(14-1), (S3)/(14-2), (S3)/(14-3);    -   (S3)/(15-4), (S3)/(15-5);    -   (S3)/(16-2);    -   (S3)/(17-1), (S3)/(17-2);    -   (S3)/(19-1), (S3)/(19-2), (S3)/(19-3), (S3)/(19-5), (S3)/(19-6),        (S3)/(19-7), (83)/(19-9), (S3)/(19-10), (S3)/(19-13);    -   (S3)/(20-1), (S3)/(20-2);    -   (S3)/(22-1), (S3)/(22-2);    -   (S3)/(23-1), (S3)/(23-2), (S3)/(23-3);    -   (S3)/(24-1), (S3)/(24-3), (S3)/(24-7);-   4. Combinations of mefenpyr-diethyl (S4) with particularly preferred    fungicidally active compounds of groups 2 to 24:    -   (S4)/(2-1), (S4)/(2-2), (S4)/(2-3), (S4)/(2-4), (S4)/(2-5),        (S4)/(2-6), (S4)/(2-8), (S4)/(2-9), (S4)/(2-10), (S4)/(2-1),        (S4)/(2-12), (S4)/(2-13);    -   (S4)/(3-3), (S4)/(3-4), (S4)/(3-6), (S4)/(3-7), (S4)/(3-8),        (S4)/(3-9), (S4)/(3-10), (4)/(3-12), (S4)/(3-13), (S4)/(3-15),        (S4)/(3-16), (S4)/(3-17), (S4)/(3-19), (S4)/(3-21), (S4)/(3-22),        (S4)/(3-23), (S4)/(3-24);    -   (S4)/(4-1), (S4)/(4-2);    -   (S4)/(5-1), (S4)/(5-3);    -   (S4)/(6-2), (S4)/(6-5), (S4)/(6-6), (S4)/(6-7), (S4)/(6-8),        (S4)/(6-9), (S4)/(6-10), (S4)/(6-11), (S4)/(6-14), (S4)/(6-16);    -   (S4)/(7-1), (S4)/(7-2), (S4)/(7-4), (S4)/(7-5), (S4)/(7-6);    -   (S4)/(8-1), (S4)/(8-2), (S4)/(8-3), (S4)/(8-4), (S4)/(8-5);    -   (S4)/(9-1), (S4)/(9-2), (S4)/(9-3);    -   (S4)/(10-1), (S4)/(10-3);    -   (S4)/(11-1), (S4)/(11-2), (S4)/(11-3), (S4)/(11-4);    -   (S4)/(12-2), (S4)/(12-3), (S4)/(12-4), (S4)/(12-5);    -   (S4)/(13-1), (S4)/(13-2), (S4)/(13-3);    -   (S4)/(14-1), (S4)/(14-2), (S4)/(14-3);    -   (S4)/(15-4), (S4)/(15-5);    -   (S4)/(16-2);    -   (S4)/(17-1), (S4)/(17-2);    -   (S4)/(19-1), (S4)/(19-2), (S4)/(19-3), (S4)/(19-5), (S4)/(19-6),        (S4)/(19-7), (S4)/(19-9), (S4)/(19-10), (S4)/(19-13);    -   (S4)/(20-1), (S4)/(20-2);    -   (S4)/(22-1), (S4)/(22-2);    -   (S4)/(23-1), (S4)/(23-2), (S4)/(23-3);    -   (S4)/(24-1), (4)/(24-3), (S4)/(24-7);-   5. Combinations of furilazole (S5) with particularly preferred    fungicidally active compounds of groups 2 to 24:    -   (S5)/(2-1), (S5)/(2-2), (S5)/(2-3), (S5)/(2-4), (S5)/(2-5),        (S5)/(2-6), (5)/(2-8), (S5)/(2-9), (S5)/(2-10), (S5)/(2-11),        (S5)/(2-12), (S5)/(2-13);    -   (S5)/(3-3), (S5)/(3-4), (S5)/(3-6), (S5)/(3-7), (5)/(3-8),        (S5)/(3-9), (S5)/(3-10), (S5)/(3-12), (S5)/(3-13), (S5)/(3-15),        (S5)/(3-16), (S5)/(3-17), (S5)/(3-19), (S5)/(3-21), (S5)/(3-22),        (S5)/(3-23), (S5)/(3-24);    -   (S5)/(4-1), (S5)/(4-2);    -   (S5)/(5-1), (S5)/(5-3);    -   (S5)/(6-2), (S5)/(6-5), (S5)/(6-6), (S5)/(6-7), (S5)/(6-8),        (S5)/(6-9), (S5)/(6-10), (S5)/(6-11), (S5)/(6-14), (S5)/(6-16);    -   (S5)/(7-1), (S5)/(7-2), (S5)/(7-4), (S5)/(7-5), (S5)/(7-6);    -   (S5)/(8-1), (S5)/(8-2), (S5)/(8-3), (S5)/(8-4), (S5)/(8-5);    -   (S5)/(9-1), (S5)/(9-2), (S5)/(9-3);    -   (S5)/(10-1), (S5)/(10-3);    -   (S5)/(11-1), (S5)/(11-2), (S5)/(11-3), (S5)/(11-4);    -   (S5)/(12-2), (S5)/(12-3), (S5)/(12-4), (S5)/(12-5);    -   (S5)/(13-1), (S5)/(13-2), (S5)/(13-3);    -   (S5)/(14-1), (S5)/(14-2), (S5)/(14-3);    -   (S5)/(15-4), (S5)/(15-5);    -   (S5)/(16-2);    -   (S5)/(17-1), (S5)/(17-2);    -   (S5)/(19-1), (S5)/(19-2), (S5)/(19-3), (S5)/(19-5), (S5)/(19-6),        (S5)/(19-7), (S5)/(19-9), (S5)/(19-10), (S5)/(19-13);    -   (S5)/(20-1), (S5)/(20-2);    -   (S5)/(22-1), (S5)/(22-2);    -   (S5)/(23-1), (S5)/(23-2), (S5)/(23-3);    -   (S5)/(24-1), (S5)/(24-3), (S5)/(24-7);-   6. Combinations of fenclorim (S6) with particularly preferred    fungicidally active compounds of groups 2 to 24:    -   (S6)/(2-1), (S6)/(2-2), (S6)/(2-3), (S6)/(2-4), (S6)/(2-5),        (S6)/(2-6), (S6)/(2-8), (S6)/(2-9), (S6)/(2-10), (S6)/(2-1 1),        (S6)/(2-12), (S6)/(2-13);    -   (S6)/(3-3), (S6)/(3-4), (S6)/(3-6), (S6)/(3-7), (S6)/(3-8),        (S6)/(3-9), (S6)/(3-10), (S6)/(3-12), (S6)/(3-13), (S6)/(3-15),        (S6)/(3-16), (S6)/(3-17), (S6)/(3-19), (S6)/(3-21), (S6)/(3-22),        (S6)/(3-23), (S6)/(3-24);    -   (S6)/(4-1), (S6)/(4-2);    -   (S6)/(5-1), (S6)/(5-3);    -   (S6)/(6-2), (S6)/(6-5), (S6)/(6-6), (S6)/(6-7), (S6)/(6-8),        (S6)/(6-9), (S6)/(6-10), (S6)/(6-11), (S6)/(6-14), (S6)/(6-16);    -   (S6)/(7-1), (S6)/(7-2), (S6)/(7-4), (S6)/(7-5), (S6)/(7-6);    -   (S6)/(8-1), (S6)/(8-2), (S6)/(8-3), (S6)/(8-4), (S6)/(8-5);    -   (S6)/(9-1), (S6)/(9-2), (S6)/(9-3);    -   (S6)/(10-1), (S6)/(10-3);    -   (S6)/(11-1), (S6)/(11-2), (S6)/(11-3), (S6)/(11-4);    -   (S6)/(12-2), (S6)/(12-3), (S6)/(12-4), (S6)/(12-5);    -   (S6)/(13-1), (S6)/(13-2), (S6)/(13-3);    -   (S6)/(14-1), (S6)/(14-2), (S6)/(14-3);    -   (S6)/(15-4), (S6)/(15-5);    -   (S6)/(16-2);    -   (S6)/(17-1), (S6)/(17-2);    -   (S6)/(19-1), (S6)/(19-2), (S6)/(19-3), (S6)/(19-5), (S6)/(19-6),        (S6)/(19-7), (S6)/(19-9), (S6)/(19-10), (S6)/(19-13);    -   (S6)/(20-1), (S6)/(20-2);    -   (S6)/(22-1), (S6)/(22-2);    -   (S6)/(23-1), (S6)/(23-2), (S6)/(23-3);    -   (S6)/(24-1), (S6)/(24-3), (S6)/(24-7);-   7. Combinations of cumyluron (S7) with particularly preferred    fungicidally active compounds of groups 2 to 24:    -   (S7)/(2-1), (S7)/(2-2), (S7)/(2-3), (S7)/(2-4), (S7)/(2-5),        (S7)/(2-6), (S7)/(2-8), (S7)/(2-9), (S7)/(2-10), (S7)/(2-11),        (S7)/(2-12), (S7)/(2-13);    -   (S7)/(3-3), (S7)/(3-4), (S7)/(3-6), (S7)/(3-7), (S7)/(3-8),        (S7)/(3-9), (S7)/(3-10), (S7)/(3-12), (S7)/(3-13), (S7)/(3-15),        (S7)/(3-16), (S7)/(3-17), (S7)/(3-19), (S7)/(3-2 1),        (S7)/(3-22),    -   (S7)/(3-23), (S7)/(3-24);    -   (S7)/(4-1), (S7)/(4-2);    -   (S7)/(5-1), (S7)/(5-3);    -   (S7)/(6-2), (S7)/(6-5), (S7)/(6-6), (S7)/(6-7), (S7)/(6-8),        (S7)/(6-9), (S7)/(6-10), (S7)/(6-11), (S7)/(6-14), (S7)/(6-16);    -   (S7)/(7-1), (S7)/(7-2), (S7)/(7-4), (S7)/(7-5), (S7)/(7-6);    -   (S7)/(8-1), (S7)/(8-2), (S7)/(8-3), (S7)/(8-4), (S7)/(8-5);    -   (S7)/(9-1), (S7)/(9-2), (S7)/(9-3);    -   (S7)/(10-1), (S7)/(10-3);    -   (S7)/(11-1), (S7)/(11-2), (S7)/(11-3), (S7)/(11-4);    -   (S7)/(12-2), (S7)/(12-3), (S7)/(12-4), (S7)/(12-5);    -   (S7)/(13-1), (S7)/(13-2), (S7)/(13-3);    -   (S7)/(14-1), (S7)/(14-2), (S7)/(14-3);    -   (S7)/(15-4), (S7)/(15-5);    -   (S7)/(16-2);    -   (S7)/(17-1), (S7)/(17-2);    -   (S7)/(19-1), (S7)/(19-2), (S7)/(19-3), (S7)/(19-5), (S7)/(19-6),        (S7)/(19-7), (S7)/(19-9), (S7)/(19-10), (S7)/(19-13);    -   (S7)/(20-1), (S7)/(20-2);    -   (S7)/(22-1), (S7)/(22-2);    -   (S7)/(23-1), (S7)/(23-2), (S7)/(23-3);    -   (S7)/(24-1), (S7)/(24-3), (S7)/(24-7);-   8. Combinations of daimuron/dymron (S8) with particularly preferred    fungicidally active compounds of groups 2 to 24:    -   (S8)/(2-1), (S8)/(2-2), (S8)/(2-3), (S8)/(2-4), (S8)/(2-5),        (S8)/(2-6), (S8)/(2-8), (S8)/(2-9), (S8)/(2-10), (S8)/(2-11),        (S8)/(2-12), (S8)/(2-13);    -   (S8)/(3-3), (S8)/(3-4), (S8)/(3-6), (S8)/(3-7), (S8)/(3-8),        (S8)/(3-9), (S8)/(3-10), (S8)/(3-12), (S8)/(3-13), (S8)/(3-15),        (S8)/(3-16), (S8)/(3-17), (S8)/(3-19), (S8)/(3-21), (S8)/(3-22),        (S8)/(3-23), (S8)/(3-24);    -   (S8)/(4-1), (S8)/(4-2);    -   (S8)/(5-1), (S8)/(5-3);    -   (S8)/(6-2), (S8)/(6-5), (S8)/(6-6), (S8)/(6-7), (S8)/(6-8),        (S8)/(6-9), (S8)/(6-10), (S8)/(6-11), (S8)/(6-14), (S8)/(6-16);    -   (S8)/(7-1), (S8)/(7-2), (S8)/(7-4), (S8)/(7-5), (S8)/(7-6);    -   (S8)/(8-1), (S8)/(8-2), (S8)/(8-3), (S8)/(8-4), (S8)/(8-5);    -   (S5)/(9-1), (S8)/(9-2), (S8)/(9-3);    -   (S8)/(10-1), (S8)/(10-3);    -   (S8)/(11-1), (S8)/(11-2), (S8)/(11-3), (S8)/(11-4);    -   (S8)/(12-2), (S8)/(12-3), (S8)/(12-4), (S8)/(12-5);    -   (S8)/(13-1), (S8)/(13-2), (S8)/(13-3);    -   (S8)/(14-1), (S8)/(14-2), (S8)/(14-3);    -   (S8)/(15-4), (S8)/(15-5);    -   (S8)/(16-2);    -   (S8)/(17-1), (S8)/(17-2);    -   (S8)/(19-1), (S8)/(19-2), (S8)/(19-3), (S8)/(19-5), (S8)/(19-6),        (S8)/(19-7), (S8)/(19-9), (S8)/(19-10), (S8)/(19-13);    -   (S8)/(20-1), (S8)/(20-2);    -   (S8)/(22-1), (S8)/(22-2);    -   (S8)/(23-1), (S8)/(23-2), (S8)/(23-3);    -   (S8)/(24-1), (S8)/(24-3), (S8)/(24-7);-   9. Combinations of dimepirate (S9) with particularly preferred    fungicidally active compounds of groups 2 to 24:    -   (S9)/(2-1), (S9)/(2-2), (S9)/(2-3), (S9)/(2-4), (S9)/(2-5),        (S9)/(2-6), (S9)/(2-8), (S9)/(2-9), (S9)/(2-10), (S9)/(2-11),        (S9)/(2-12), (S9)/(2-13);    -   (S9)/(3-3), (S9)/(3-4), (S9)/(3-6), (S9)/(3-7), (S9)/(3-8),        (S9)/(3-9), (S9)/(3-10), (S9)/(3-12), (S9)/(3-13), (S9)/(3-15),        (S9)/(3-16), (S9)/(3-17), (S9)/(3-19), (S9)/(3-21), (S9)/(3-22),    -   (S9)/(3-23), (S9)/(3-24);    -   (S9)/(4-1), (S9)/(4-2);    -   (S9)/(5-1), (S9)/(5-3);    -   (S9)/(6-2), (S9)/(6-5), (S9)/(6-6), (S9)/(6-7), (S9)/(6-8),        (S9)/(6-9), (S9)/(6-10), (S9)/(6-11), (S9)/(6-14), (S9)/(6-16);    -   (S9)/(7-1), (S9)/(7-2), (S9)/(7-4), (S9)/(7-5), (S9)/(7-6);    -   (S9)/(8-1), (S9)/(8-2), (S9)/(8-3), (S9)/(8-4), (S9)/(8-5);    -   (S9)/(9-1), (S9)/(9-2), (S9)/(9-3);    -   (S9)/(10-1), (S9)/(10-3);    -   (S9)/(11-1), (S9)/(11-2), (S9)/(11-3), (S9)/(11-4);    -   (S9)/(12-2), (S9)/(12-3), (S9)/(12-4), (S9)/(12-5);    -   (S9)/(13-1), (S9)/(13-2), (S9)/(13-3);    -   (S9)/(14-1), (S9)/(14-2), (S9)/(14-3);    -   (S9)/(15-4), (S9)/(15-5);    -   (S9)/(16-2);    -   (S9)/(17-1), (S9)/(17-2);    -   (S9)/(19-1), (S9)/(19-2), (S9)/(19-3), (S9)/(19-5), (S9)/(19-6),        (S9)/(19-7), (S9)/(19-9),    -   (S9)/(19-10), (S9)/(19-13);    -   (S9)/(20-1), (S9)/(20-2);    -   (S9)/(22-1), (S9)/(22-2);    -   (S9)/(23-1), (S9)/(23-2), (S9)/(23-3);    -   (S9)/(24-1), (S9)/(24-3), (S9)/(24-7);-   10. Combinations of the compound (I-e-11) (S10) with particularly    preferred fungicidally active compounds of groups 2 to 24:    -   (S10)/(2-1), (S10)/(2-2), (S10)/(2-3), (S10)/(2-4), (S10)/(2-5),        (S10)/(2-6), (S10)/(2-8), (S10)/(2-9), (S10)/(2-10),        (S10)/(2-11), (S10)/(2-12), (S10)/(2-13);    -   (S10)/(3-3), (S10)/(3-4), (S10)/(3-6), (S10)/(3-7), (S10)/(3-8),        (S10)/(3-9), (S10)/(3-10), (S10)/(3-12), (S10)/(3-13),        (S10)/(3-15), (S10)/(3-16), (S10)/(3-17), (S10)/(3-19),        (S10)/(3-21), (S10)/(3-22), (S10)/(3-23), (S10)/(3-24);    -   (S10)/(4-1), (S10)/(4-2);    -   (S10)/(5-1), (S10)/(5-3);    -   (S10)/(6-2), (S10)/(6-5), (S10)/(6-6), (S10)/(6-7), (S10)/(6-8),        (S10)/(6-9), (S10)/(6-10), (S10)/(6-11), (S10)/(6-14),        (S10)/(6-16);    -   (S10)/(7-1), (S10)/(7-2), (S10)/(7-4), (S10)/(7-5), (S10)/(7-6);    -   (S10)/(8-1), (S10)/(8-2), (S10)/(8-3), (S10)/(8-4), (S10)/(8-5);    -   (S10)/(9-1), (S10)/(9-2), (S10)/(9-3);    -   (S10)/(10-1), (S10)/(10-3);    -   (S10)/(11-1), (S10)/(11-2), (S10)/(11-3), (S10)/(11-4);    -   (S10)/(12-2), (S10)/(12-3), (S10)/(12-4), (S10)/(12-5);    -   (S10)/(13-1), (S10)/(13-2), (S10)/(13-3);    -   (S10)/(14-1), (S10)/(14-2), (S10)/(14-3);    -   (S10)/(15-4), (10)/(15-5);    -   (S10)/(16-2);    -   (S10)/(17-1), (S10)/(17-2);    -   (S10)/(19-1), (S10)/(19-2), (S10)/(19-3), (S10)/(19-5),        (S10)/(19-6), (S10)/(19-7),    -   (S10)/(19-9), (S10)/(19-10), (S10)/(19-13);    -   (S10)/(20-1), (S10)/(20-2);    -   (S10)/(22-1), (S10)/(22-2);    -   (S10)/(23-1), (S10)/(23-2), (S10)/(23-3);    -   (S10)/(24-1), (S10)/(24-3), (S10)/(24-7);-   11. Combinations of the compound (I-e-5) (S11) with particularly    preferred fungicidally active compounds of groups 2 to 24:    -   (S11)/(2-1), (S11)/(2-2), (S11)/(2-3), (S11)/(2-4), (S11)/(2-5),        (S11)/(2-6), (S11)/(2-8), (S11)/(2-9), (S11)/(2-10),        (S11)/(2-11), (S11)/(2-12), (S11)/(2-13);    -   (S11)/(3-3), (S11)/(3-4), (S11)/(3-6), (S11)/(3-7), (S11)/(3-8),        (S11)/(3-9), (S11)/(3-10), (S11)/(3-12), (S11)/(3-13),        (S11)/(3-15), (S11)/(3.16), (S11)/(3-17), (S11)/(3-19),        (S11)/(3-21), (S11)/(3-22), (S1)/(3-23), (S11)/(3-24);    -   (S11)/(4-1), (S11)/(4-2);    -   (S11)/(5-1), (S11)/(5-3);    -   (S11)/(6-2), (S11)/(6-5), (S11)/(6-6), (S11)/(6-7), (S11)/(6-8),        (S11)/(6-9), (S11)/(6-10), (S11)/(6-11), (S11)/(6-14),        (S11)/(6-16);    -   (S11)/(7-1), (S11)/(7-2), (S11)/(7-4), (S11)/(7-5), (S11)/(7-6);    -   (S11)/(8-1), (S11)/(8-2), (S11)(8-3), (S11)/(8-4), (S11)/(8-5);    -   (S11)/(9-1), (S11)/(9-2), (S11)/(9-3);    -   (S11)/(10-1), (S11)/(10-3);    -   (S11)/(11-1), (S11)/(11-2), (S11)/(11-3), (S11)/(11-4);    -   (S11)/(12-2), (S11)/(12-3), (S11)/(12-4), (S11)/(12-5);    -   (S11)/(13-1), (S11)/(13-2), (S11)/(13-3);    -   (S11)/(14-1), (S11)/(14-2), (S11)/(14-3);    -   (S11)/(15-4), (S11)/(15-5);    -   (S11)/(16-2);    -   (S11)/(17-1), (S11)/(17-2);    -   (S11)/(19-1), (S11)/(19-2), (S11)/(19-3), (S11)/(19-5),        (S11)/(19-6), (S11)/(19-7), (S11)/(19-9), (S11)/(19-10),        (S11)/(19-13);    -   (S11)/(20-1), (S11)/(20-2);    -   (S11)/(22-1), (S11)/(22-2);    -   (S11)/(23-1), (S11)/(23-2), (S11)/(23-3);    -   (S11)/(24-1), (S11)/(24-3), (S11)/(24-7);

Particular preference is furthermore given to combinations of safeners,in particular the compounds (S1) to S11), and systemic fungicides, inparticular those from groups 2 to 24.

In addition to a safener, the combinations according to the inventioncomprise at least one active compound from the compounds of groups (2)to (24).

As such or in their formulations, the combinations according to theinvention can also be used as a mixture with further known fungicides,preferably from groups 1 to 24, bactericides, acaricides, nematicides orinsecticides—in particular when treating seed—to broaden the activityspectrum or to prevent the development of resistance, for example.

Preference is given, for example, to combinations of safeners, inparticular the compounds (S1) to (S11), and the following fungicidecombinations:

-   prothioconazole and fluoxastrobin,-   prothioconazole and trifloxystrobin,-   prothioconazole and spiroxamine,-   prothioconazole and tebuconazole,-   prothioconazole and prochloraz,-   fluoxastrobin and trifloxystrobin,-   fluoxastrobin and spiroxamine,-   fluoxastrobin and tebunconazole,-   fluoxastrobin and prochloraz,-   trifloxystrobin and spiroxamine-   trifloxystrobin and tebuconazole-   trifloxystrobin and prochloraz,-   spiroxamine and tebuconazole,-   spiroxamine and prochloraz,-   tebucanozole and prochloraz.

Preference is furthermore given to the following combinations:

-   mefenpyr-diethyl and prothioconazole,-   mefenpyr-diethyl and fluoxastrobin,-   mefenpyr-diethyl and trifloxystrobin,-   mefenpyr-diethyl and spiroxamine,-   mefenpyr-diethyl and tebuconazole,-   mefenpyr-diethyl and prochloraz,-   in each case in combination with a further compound from 2 to 24.

A mixture with other known active compounds, such as herbicides, or withfertilizers and growth regulators is also possible.

If the safeners and fungicides in the active compound combinationsaccording to the invention are present in particular weight ratios, theactivity-enhancing (synergistic) effect is particularly pronounced.However, the weight ratios of the active compounds in the activecompound combinations can be varied within a relatively wide range. Ingeneral, the combinations according to the invention comprise safenerand a fungicide from one of groups (2) to (24) in the mixing ratiosgiven in an exemplary manner in the table below.

The mixing ratios are based on weight ratios. The ratio is to beunderstood as meaning active compound of formula (I): mixing partner.

TABLE 22 Mixing ratios Particularly Preferred preferred Mixing partnermixing ratio mixing ratio Group (2): strobilurins 50:1 to 1:50 10:1 to1:20 Group (3): triazoles without (3-15) 50:1 to 1:50 20:1 to 1:20(3-15): prothioconazole 50:1 to 1:50 10:1 to 1:20 Group (4):sulphenamides  1:1 to 1:150  1:1 to 1:100 Group (5): valinamides 50:1 to1:50 10:1 to 1:20 Group (6): carboxamides 50:1 to 1:50 20:1 to 1:20Group (7): dithiocarbamates  1:1 to 1:150  1:1 to 1:100 Group (8):acylalanines  10:1 to 1:150  5:1 to 1:100 Group (9): anilino-pyrimidines 5:1 to 1:50  1:1 to 1:20 Group (10): benzimidazoles 10:1 to 1:50  5:1to 1:20 Group (11): carbamates without (11-1)  1:1 to 1:150  1:1 to1:100 (11-1): diethofencarb 50:1 to 1:50 10:1 to 1:20 Group (12):(12-1)/(12-2)/12-3)  1:1 to 1:150  1:5 to 1:100 Group (12):(12-4)/(12-5)/12-6)  5:1 to 1:50  1:1 to 1:20 Group (13): guanidines100:1 to 1:150  20:1 to 1:100 Group (14): imidazoles 50:1 to 1:50 10:1to 1:20 Group (15): morpholines 50:1 to 1:50 10:1 to 1:20 Group (16):pyrroles 50:1 to 1:50 10:1 to 1:20 Group (17): phosphonates  10:1 to1:150  1:1 to 1:100 Group (18): phenylethanamides 50:1 to 1:50 10:1 to1:20 (19-1): acibenzolar-S-methyl 50:1 to 1:50 20:1 to 1:20 (19-2):chlorothalonil  1:1 to 1:150  1:1 to 1:100 (19-3): cymoxanil 10:1 to1:50  5:1 to 1:20 (19-4): edifenphos 10:1 to 1:50  5:1 to 1:20 (19-5):famoxadone 50:1 to 1:50 10:1 to 1:20 (19-6): fluazinam 50:1 to 1:50 10:1to 1:20 (19-7): copper oxychloride  1:1 to 1:150  1:5 to 1:100 (19-8):copper hydroxide  1:1 to 1:150  1:5 to 1:100 (19-9): oxadixyl  10:1 to1:150  5:1 to 1:100 (19-10): spiroxamine 50:1 to 1:50 10:1 to 1:20(19-11) dithianon 50:1 to 1:50 10:1 to 1:20 (19-12) metrafenone 50:1 to1:50 10:1 to 1:20 (19-13) fenamidone 50:1 to 1:50 10:1 to 1:20 (19-14):2,3-dibutyl-6-chlorothieno- 50:1 to 1:50 10:1 to 1:20[2,3-d]pyrimidin-4(3H)one (19-15): probenazole  10:1 to 1:150  5:1 to1:100 (19-16): isoprothiolane  10:1 to 1:150  5:1 to 1:100 (19-17):kasugamycin 50:1 to 1:50 10:1 to 1:20 (19-18): phthalide  10:1 to 1:150 5:1 to 1:100 (19-19): ferimzone 50:1 to 1:50 10:1 to 1:20 (19-20):tricyclazole 50:1 to 1:50 10:1 to 1:20 (19-21):N-({4-[(cyclopropylamino)-  10:1 to 1:150  5:1 to 1:100carbonyl]phenyl}sulphonyl)-2- methoxybenzamide Group (20): (thio)ureaderivatives 50:1 to 1:50 10:1 to 1:20 Group (21): amides 50:1 to 1:5010:1 to 1:20 Group (22): triazolopyrimidines 50:1 to 1:50 10:1 to 1:20Group (23): iodochromone 50:1 to 1:50 10:1 to 1:20 Group (24):biphenylcarboxamides 50:1 to 1:50 10:1 to 1:20

In each case, the mixing ratio is to be chosen such that a synergisticmixture is obtained. The mixing ratios of safener and a compound fromone of groups (2) to (24) may also vary between the individual compoundsof a group.

The compounds of group 1 and of groups 2 to 24 can be appliedsimultaneously, that is jointly or separately, or in succession, thesequence in the case of separate application generally not having anyeffect on the control results.

The combinations according to the invention have very good fungicidalproperties and can be used for controlling phytopathogenic fungi, suchas plasmodiophoromycetes, oomycetes, chytridiomycetes, zygomycetes,ascomycetes, basidiomycetes, deuteromycetes etc.

The combinations according to the invention are particularly suitablefor controlling Erysiphe graminis, Pyrenophora teres and Leptosphaerianodorum.

Some pathogens causing fungal and bacterial diseases which come underthe generic names listed above may be mentioned as examples, but not byway of limitation:

Xanthomonas species, such as, for example, Xanthomonas campestris pv.oryzae;

Pseudomonas species, such as, for example, Pseudomonas syringae pv.lachrymans;

Erwinia species, such as, for example, Erwinia amylovora;

Diseases caused by powdery mildew pathogens, such as, for example,

Blumeria species, such as, for example, Blumeria graminis;

Podosphaera species, such as, for example, Podosphaera leucotricha;

Sphaerotheca species, such as, for example, Sphaerotheca fuliginea;

Uncinula species, such as, for example, Uncinula necator;

Diseases caused by rust disease pathogens, such as, for example,

Gymnosporangium species, such as, for example, Gymnosporangium sabinae

Hemileia species, such as, for example, Hemileia vastatrix;

Phakopsora species, such as, for example, Phakopsora pachyrhizi andPhakopsora meibomiae;

Puccinia species, such as, for example, Puccinia recondita;

Uromyces species, such as, for example, Uromyces appendiculatus;

Diseases caused by pathogens from the group of the Oomycetes, such as,for example,

Bremia species, such as, for example, Bremia lactucae;

Peronospora species, such as, for example, Peronospora pisi or P.brassicae;

Phytophthora species, such as, for example Phytophthora infestans;

Plasmopara species, such as, for example, Plasmopara viticola;

Pseudoperonospora species, such as, for example, Pseudoperonosporahumuli or Pseudoperonospora cubensis;

Pythium species, such as, for example, Pythium ultimum;

Leaf blotch diseases and leaf wilt diseases caused, for example, by

Alternaria species, such as, for example, Alternaria solani;

Cercospora species, such as, for example, Cercospora beticola;

Cladiosporum species, such as, for example, Cladiosporium cucumerinum;

Cochliobolus species, such as, for example, Cochliobolus sativus(conidia form: Drechslera, Syn: Helminthosporium);

Colletotrichum species, such as, for example, Colletotrichumlindemuthanium;

Cycloconium species, such as, for example, Cycloconium oleaginum;

Diaporthe species, such as, for example, Diaporthe citri;

Elsinoe species, such as, for example, Elsinoe fawcettii;

Gloeosporium species, such as, for example, Gloeosporium lacticolor;

Glomerella species, such as, for example, Glomerella cingulata;

Guignardia species, such as, for example, Guignardia bidwelli;

Leptosphaeria species, such as, for example, Leptosphaeria maculans;

Magnaporthe species, such as, for example, Magnaporthe grisea;

Mycosphaerella species, such as, for example, Mycosphaerellagraminicola;

Phaeosphaeria species, such as, for example, Phaeosphaeria nodorum;

Pyrenophora species, such as, for example, Pyrenophora teres;

Ramularia species, such as, for example, Ramularia collo-cygni;

Rhynchosporium species, such as, for example, Rhynchosporium secalis;

Septoria species, such as, for example, Septoria apii;

Typhula species, such as, for example, Typhula incarnata;

Venturia species, such as, for example, Venturia inaequalis;

Root and stem diseases caused, for example, by

Corticium species, such as, for example, Corticium graminearum;

Fusarium species, such as, for example, Fusarium oxysporum;

Gaeumannomyces species, such as, for example, Gaeumannomyces graminis;

Rhizoctonia species, such as, for example Rhizoctonia solani;

Tapesia species, such as, for example, Tapesia acuformis;

Thielaviopsis species, such as, for example, Thielaviopsis basicola;

Ear and panicle diseases (including maize crops) caused, for example, by

Alternaria species, such as, for example, Alternaria spp.;

Aspergillus species, such as, for example, Aspergillus flavus;

Cladosporium species, such as, for example, Cladosporium spp.;

Claviceps species, such as, for example, Claviceps purpurea;

Fusarium species, such as, for example, Fusarium culmorum;

Gibberella species, such as, for example, Gibberella zeae;

Monographella species, such as, for example, Monographella nivalis;

Diseases caused by smut fungi, such as, for example,

Sphacelotheca species, such as, for example, Sphacelotheca reiliana;

Tilletia species, such as, for example, Tilletia caries;

Urocystis species, such as, for example, Urocystis occulta;

Ustilago species, such as, for example, Ustilago nuda;

Fruit rot caused, for example, by

Aspergillus species, such as, for example, Aspergillus flavus;

Botrytis species, such as, for example, Botrytis cinerea;

Penicillium species, such as, for example, Penicillium expansum;

Sclerotinia species, such as, for example, Sclerotinia selerotiorum;

Verticilium species, such as, for example, Verticilium alboatrum;

Seed- and soil-borne rot and wilt diseases, and also diseases ofseedlings, caused, for example, by

Fusarium species, such as, for example, Fusarium culmorum;

Phytophthora species, such as, for example, Phytophthora cactrum;

Pythium species, such as, for example, Pythium ultimum;

Rhizoctonia species, such as, for example, Rhizoctonia solani;

Sclerotium species, such as, for example, Sclerotium rolfsii;

Cancerous diseases, galls and witches' broom caused, for example, by

Nectria species, such as, for example, Nectria galligena;

Wilt diseases caused, for example, by

Monilinia species, such as, for example, Monilinia laxa;

Deformations of leaves, flowers and fruits caused, for example, by

Taphrina species, such as, for example, Taphrina deformans;

Degenerative diseases of woody plants caused, for example, by

Esca species, such as, for example, Phaemoniella clamydospora;

Diseases of flowers and seeds caused, for example, by

Botrytis species, such as, for example, Botrytis cinerea;

Diseases of plant tubers caused, for example, by

Rhizoctonia species, such as, for example, Rhizoctonia solani.

The fact that the combination is well tolerated by plants at theconcentrations required for controlling plant diseases permits atreatment of entire plants (above-ground parts of plants and roots), ofpropagation stock and seed, and of the soil. The combinations accordingto the invention can be used for foliar application or else as seeddressings.

The fact that the combinations which can be used are well tolerated byplants at the concentrations required for controlling plant diseasespermits a treatment of the seed. Accordingly, the combinations accordingto the invention can be used as seed dressings.

A large part of the damage to crop plants which is caused byphytopathogenic fungi occurs as early as when the seed is attackedduring storage and after the seed is introduced into the soil, as wellas during and immediately after germination of the plants. This phase isparticularly critical since the roots and shoots of the growing plantare particularly sensitive and even minor damage can lead to the deathof the whole plant. Protecting the seed and the germinating plant by theuse of suitable compositions is therefore of particularly greetinterest.

The control of phytopathogenic fungi which damage plants post-emergenceis carried out primarily by treating the soil and the above-ground partsof plants with crop protection agents. Owing to the concerns regarding apossible impact of crop protection agents on the environment and thehealth of man and animals, there are efforts to reduce the amount ofactive compounds applied.

The control of phytopathogenic fungi by treating the seeds of plants hasbeen known for a long time and is subject-matter of continuousimprovements. However, the treatment of seed frequently entails a seriesof problems which cannot always be solved in a satisfactory manner.Thus, it is desirable to develop methods for protecting the seed and thegerminating plant which dispense with the additional application of cropprotection agents after sowing or after the emergence of the plants orwhere additional application is at least reduced. It is furthermoredesirable to optimize the amount of active compound employed in such away as to provide maximum protection for the seed and the germinatingplant from attack by phytopathogenic fungi, but without damaging theplant itself by the active compound employed. In particular, methods forthe treatment of seed should also take into consideration the intrinsicfungicidal properties of transgenic plants in order to achieve optimumprotection of the seed and the germinating plant with a minimum of cropprotection agents being employed.

The present invention therefore in particular also relates to a methodfor the protection of seed and germinating plants from attack byphytopathogenic fungi, by treating the seed with a combination accordingto the invention.

The invention likewise relates to the use of the combination accordingto the invention for the treatment of seed for protecting the seed andthe germinating plant from phytopathogenic fungi.

Furthermore, the invention relates to seed which has been treated, inparticular coated, with a combination according to the invention so asto afford protection from phytopathogenic fungi.

One of the advantages of the present invention is that, when systemicfungicides are used, treatment of the seed with the combinationsaccording to the invention not only protects the seed itself, but alsothe resulting plants after emergence, from phytopathogenic fungi. Inthis manner, the immediate treatment of the crop at the time of sowingor shortly thereafter can be dispensed with.

Furthermore, it must be considered as advantageous that the combinationsaccording to the invention can also be employed in particular intransgenic seed.

The combinations according to the invention are suitable for protectingseed of any plant variety which is employed in agriculture, in thegreenhouse, in forests or in horticulture. In particular, this takes theform of seed of cereals (such as wheat, barley, rye, millet and oats),maize, cotton, soya beans, rice, potatoes, sunflowers, beans, coffee,beet (for example sugar beet and fodder beet), peanuts, vegetables (suchas tomatoes, cucumbers, onions and lettuce), lawn and ornamental plants.The treatment of seed of cereals (such as wheat, barley, rye and oats),maize and rice is of particular importance.

In the context of the present invention, the combination according tothe invention is applied to the seed either alone or in a suitableformulation. Preferably, the seed is treated in a state which is stableenough to avoid damage during treatment. In general, the seed may betreated at any point in time between harvest and sowing. The seedusually used has been separated from the plant and freed from cobs,shells, stalks, coats, hairs or the flesh of the fruits. Thus, forexample, it is possible to use seed which has been harvested, cleanedand dried to a moisture content of below 15% by weight. Alternatively,it is also possible to use seed which, after drying, has, for example,been treated with water and then dried again.

When treating the seed, care must generally be taken that the amount ofthe combination according to the invention applied to the seed and/orthe amount of further additives is chosen in such a way that thegermination of the seed is not adversely affected, or that the resultingplant is not damaged. This must be borne in mind in particular in thecase of active compounds which may have phytotoxic effects at certainapplication rates.

The combinations according to the invention can be applied directly,that is to say without comprising further components and without havingbeen diluted. In general, it is preferable to apply the composition tothe seed in the form of a suitable formulation. Suitable formulationsand methods for the treatment of seed are known to the skilled workerand are described, for example, in the following documents: U.S. Pat.Nos. 4,272,417, 4,245,432, 4,808,430, 5,876,739, US 2003/0176428 A1, WO2002/080675 A1, WO 2002/028186 A2.

The combinations according to the invention are also suitable forincreasing the yield of crops. In addition, they show reduced toxicityand are well tolerated by plants.

According to the invention, it is possible to treat all plants and partsof plants. Plants are to be understood here as meaning all plants andplant populations, such as desired and undesired wild plants or cropplants (including naturally occurring crop plants). Crop plants can beplants which can be obtained by conventional breeding and optimizationmethods or by biotechnological and genetic engineering methods orcombinations of these methods, including the transgenic plants andincluding plant cultivars which can or cannot be protected by plantbreeders' certificates. Parts of plants are to be understood as meaningall above-ground and below-ground parts and organs of plants, such asshoot, leaf, flower and root, examples which may be mentioned beingleaves, needles, stems, trunks, flowers, fruit-bodies, fruits and seedsand also roots, tubers and rhizomes. Parts of plants also includeharvested material and vegetative and generative propagation material,for example seedlings, tubers, rhizomes, cuttings and seeds.

The treatment of the plants and parts of plants according to theinvention with the active compounds is carried out directly or by actionon their environment, habitat or storage area according to customarytreatment methods, for example by dipping, spraying, evaporating,atomizing, broadcasting, brushing-on and, in the case of propagationmaterial, in particular in the case of seeds, furthermore by one- ormultilayer coating.

As already mentioned above, it is possible to treat all plants and theirparts according to the invention. In a preferred embodiment, wild plantspecies and plant cultivars, or those obtained by conventionalbiological breeding, such as crossing or protoplast fusion, and partsthereof, are treated. In a further preferred embodiment, transgenicplants and plant cultivars obtained by genetic engineering, ifappropriate in combination with conventional methods (GeneticallyModified Organisms), and parts thereof, are treated. The term “parts” or“parts of plants” or “plant parts” has been explained above.

Particularly preferably, plants of the plant cultivars which are in eachcase commercially available or in use are treated according to theinvention.

Depending on the plant species or plant cultivars, their location andgrowth conditions (soils, climate, vegetation period, diet), thetreatment according to the invention may also result in superadditive(“synergistic”) effects. Thus, for example, reduced application ratesand/or a widening of the activity spectrum and/or an increase in theactivity of the substances and compositions which can be used accordingto the invention, better plant growth, increased tolerance to high orlow temperatures, increased tolerance to drought or to water or soilsalt content, increased flowering performance, easier harvesting,accelerated maturation, higher harvest yields, better quality and/or ahigher nutritional value of the harvested products, better storagestability and/or processability of the harvested products are possiblewhich exceed the effects which were actually to be expected.

The transgenic plants or plant cultivars (i.e. those obtained by geneticengineering) which are preferably to be treated according to theinvention include all plants which, in the genetic modification,received genetic material which imparted particularly advantageoususeful properties (“traits”) to these plants. Examples of suchproperties are better plant growth, increased tolerance to high or lowtemperatures, increased tolerance to drought or to water or soil saltcontent, increased flowering performance, easier harvesting, acceleratedmaturation, higher harvest yields, better quality and/or a highernutritional value of the harvested products, better storage stabilityand/or processability of the harvested products. Further andparticularly emphasized examples of such properties are a better defenceof the plants against animal and microbial pests, such as againstinsects, mites, phytopathogenic fungi, bacteria and/or viruses, and alsoincreased tolerance of the plants to certain herbicidally activecompounds. Examples of transgenic plants which may be mentioned are theimportant crop plants, such as cereals (wheat, rice), maize, soya beans,potatoes, cotton, oilseed rape and also fruit plants (with the fruitsapples, pears, citrus fruits and grapes), and particular emphasis isgiven to maize, soya beans, potatoes, cotton and oilseed rape. Traitsthat are emphasized are in particular increased defence of the plantsagainst insects, by toxins formed in the plants, in particular thoseformed in the plants by the genetic material from Bacillus thuringiensis(for example by the genes CryIA(a), CryIA(b), CryIA(c), CryIIA, CryIIIA,CryIIIB2, Cry9c, Cry2Ab, Cry3Bb and CryIF and also combinations thereof)(hereinbelow referred to as “Bt plants”). Traits that are furthermoreparticularly emphasized are the increased tolerance of the plants tocertain herbicidally active compounds, for example imidazolinones,sulphonylureas, glyphosate or phosphinotricin (for example the “PAT”gene). The genes which impart the desired traits in question can also bepresent in combination with one another m the transgenic plants.Examples of “Bt plants” which may be mentioned are maize varieties,cotton varieties, soya bean varieties and potato varieties which aresold under the trade names YIELD GARD® (for example maize, cotton, soyabeans), KnockOut® (for example maize), Bollgard® (cotton), Nucotn®(cotton) and NewLeaf® (potato). Examples of herbicide-tolerant plantswhich may be mentioned are maize varieties, cotton varieties and soyabean varieties which are sold under the trade names Roundup Ready®(tolerance to glyphosate, for example maize, cotton, soya bean), LibertyLink® (tolerance to phosphinotricin, for example oilseed rape), IMI®(tolerance to imidazolinones) and STS4® (tolerance to sulphonylureas,for example maize). Herbicide-resistant plants (plants bred in aconventional manner for herbicide tolerance) which may be mentioned alsoinclude the varieties sold under the name Clearfield® (for examplemaize). Of course, these statements also apply to plant cultivars whichhave these genetic traits or genetic traits still to be developed, andwhich will be developed and/or marketed in the future.

Depending on their particular physical and/or chemical properties, thecombinations according to the invention can be converted into thecustomary formulations, such as solutions, emulsions, suspensions,powders, dusts, foams, pastes, soluble powders, granules, aerosols,suspoemulsion concentrates, natural and synthetic materials impregnatedwith active compound and microencapsulations in polymeric substances andin coating compositions for seeds, and ULV cool and warm foggingformulations.

These formulations are produced in a known manner, for example by mixingthe active compounds or active compound combinations with extenders,that is liquid solvents, liquefied gases under pressure, and/or solidcarriers, optionally with the use of surfactants, that is emulsifiersand/or dispersants, and/or foam formers.

If the extender used is water, it is also possible to employ, forexample, organic solvents as auxiliary solvents. Essentially, suitableliquid solvents are: aromatics such as xylene, toluene oralkylnaphthalenes, chlorinated aromatics or chlorinated aliphatichydrocarbons such as chlorobenzenes, chloroethylenes or methylenechloride, aliphatic hydrocarbons such as cyclohexane or paraffins, forexample petroleum fractions, mineral and vegetable oils, alcohols suchas butanol or glycol and their ethers and esters, ketones such asacetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone,strongly polar solvents such as dimethylformamide and dimethylsulphoxide, or else water.

Liquefied gaseous extenders or carriers are to be understood as meaningliquids which are gaseous at standard temperature and under atmosphericpressure, for example aerosol propellants such as butane, propane,nitrogen and carbon dioxide.

Suitable solid carriers are: for example ammonium salts and groundnatural minerals such as kaolins, clays, talc, chalk, quartz,attapulgite, montmorillonite or diatomaceous earth, and ground syntheticminerals such as finely divided silica, alumina and silicates. Suitablesolid carriers for granules are: for example crushed and fractionatednatural rocks such as calcite, marble, pumice, sepiolite and dolomite,or else synthetic granules of inorganic and organic meals, and granulesof organic material such as sawdust, coconut shells, maize cobs andtobacco stalks. Suitable emulsifiers and/or foam formers are: forexample nonionic and anionic emulsifiers, such as polyoxyethylene fattyacid esters, polyoxyethylene fatty alcohol ethers, for example alkylarylpolyglycol ethers, alkylsulphonates, alkyl sulphates, arylsulphonates,or else protein hydrolysates.

Suitable dispersants are: for example lignosulphite waste liquors andmethylcellulose.

Tackifiers such as carboxymethylcellulose, natural and syntheticpolymers in the form of powders, granules or latices, such as gumarabic, polyvinyl alcohol and polyvinyl acetate, or else naturalphospholipids such as cephalins and lecithins and syntheticphospholipids can be used in the formulations. Other possible additivesare mineral and vegetable oils.

It is possible to use colorants such as inorganic pigments, for exampleiron oxide, titanium oxide and Prussian Blue, and organic dyestuffs suchas alizarin dyestuffs, azo dyestuffs and metal phthalocyanine dyestuffs,and trace nutrients such as salts of iron, manganese, boron, copper,cobalt, molybdenum and zinc.

The active compound content of the use forms prepared from thecommercial formulations may be varied within wide ranges. Theconcentration of active compound of the use forms for controlling animalpests, such as insects and acarids, may be from 0.0000001 to 95% byweight of active compound and is preferably from 0.0001 to 1% by weight.Application is in a manner adapted to the use forms.

The formulations for controlling unwanted phytopathogenic fungigenerally comprise between 0.1 and 95% by weight of active compounds,preferably between 0.5 and 90%.

The combinations according to the invention can be used as such, in theform of their formulations or as the use forms prepared therefrom, suchas ready-to-use solutions, emulsifiable concentrates, emulsions,suspensions, wettable powders, soluble powders, dusts and granules. Theyare used in a customary manner, for example by watering (drenching),drip irrigation, spraying, atomizing, broadcasting, dusting, foaming,spreading-on, and as a powder for dry seed treatment, a solution forseed treatment, a water-soluble powder for seed treatment, awater-soluble powder for slurry treatment, or by encrusting etc.

The combinations according to the invention can, in commercialformulations and in the use forms prepared from these formulations, bepresent as a mixture with other active compounds, such as insecticides,attractants, sterilants, bactericides, acaricides, nematicides,fungicides, growth regulators or herbicides.

The combinations according to the invention can be appliedsimultaneously, that is jointly or separately, or in succession, thesequence in the case of separate application generally not having anyeffect on the control results. In a preferred embodiment, thecombination according to the invention is applied simultaneously,preferably jointly.

In a further preferred embodiment, the combination according to theinvention is applied in succession.

When using the active compound combinations according to the invention,the application rates can be varied within a relatively wide range,depending on the kind of application. In the treatment of parts ofplants, the application rates of active compound combination aregenerally between 0.1 and 10 000 g/ha, preferably between 10 and 1000g/ha. In the treatment of seed, the application rates of active compoundcombination are generally between 0.001 and 50 g per kilogram of seed,preferably between 0.01 and 10 g per kilogram of seed. In the treatmentof the soil, the application rates of active compound combination aregenerally between 0.1 and 10 000 g/ha, preferably between 1 and 5000g/ha.

The combinations can be used as such, in the form of concentrates or inthe form of generally customary formulations, such as powders, granules,solutions, suspensions, emulsions or pastes.

The formulations mentioned can be prepared in a manner known per se, forexample by mixing the active compounds with at least one solvent ordiluent, emulsifier, dispersant and/or binder or fixative, waterrepellent, if desired desiccants and UV stabilizers, and, if desired,colorants and pigments and other processing auxiliaries.

Accordingly, the invention also provides a fungicidal compositioncomprising one or more safeners of group 1 and one or more fungicides ofgroups 2 to 24, except for the following safener/fungicidalcombinations:

-   -   daimuron and metominostrobin,    -   oxabetrinil and metalaxyl,    -   N-methylsulphonyloxyphenyl-N-methylthiolcarbamate and        kasugamycin.

Preferably, the fungicidal composition according to the inventioncomprises one or more of the safeners from group 1 mentioned as beingpreferred and one or more of the fungicides from groups 2 to 24mentioned as being preferred.

Particularly preferably, the fungicidal composition according to theinvention comprises one or more of the safeners from group 1 mentionedas being particularly preferred and one or more of the fungicides fromgroups 2 to 24 mentioned as being particularly preferred.

Very particularly preferably, the fungicidal composition according tothe invention comprises one or more of the safeners from group 1mentioned as being very particularly preferred and one or more of thefungicides from groups 2 to 24 mentioned as being very particularlypreferred.

Especially preferred are fungicidal compositions according to theinvention comprising one of the especially preferred combinations ofsafener and fungicide.

The good fungicidal action of the combinations according to theinvention is demonstrated by the examples below. While the individualactive compounds show weaknesses in their fungicidal action, thecombinations show an action which exceeds a simple sum of actions,although the safeners used according to the invention generally do nothave any fungicidal action.

A synergistic effect in the fungicides is always present when thefungicidal action of the active compound combinations exceeds the totalof the action of the active compounds when applied individually.

The expected fungicidal action for a given combination of two activecompounds can be calculated as follows, according to S. R. Colby(“Calculating Synergistic and Antagonistic Responses of HerbicideCombinations”, Weeds 1967, 15, 20-22):

If

-   X is the efficacy when employing active compound A at an application    rate of m g/ha,-   Y is the efficacy when employing active compound B at an application    rate of n g/ha and-   E is the efficacy when employing active compounds A and B at    application rates of m and n g/ha,    then

$E = {X + Y - \frac{X \times Y}{100}}$

Here, the efficacy is determined in %. 0% means an efficacy whichcorresponds to that of the control, whereas an efficacy of 100% meansthat no infection is observed.

If the actual fungicidal action exceeds the calculated value, the actionof the combination is superadditive, i.e. a synergistic effect ispresent. In this case, the actually observed efficacy must exceed thevalue calculated using the above formula for the expected efficacy (E).

The invention is illustrated by the examples below. However, theinvention is not limited to the examples.

EXAMPLE

Erysiphe Test (Wheat)/Curative

To prepare a suitable preparation of active compound, a commercialformulation of active compound is diluted with water to the desiredconcentration.

To test for curative activity, young plants were dusted with spores ofErysiphe graminis f.sp. tritici. 48 hours after the inoculation, theplants were sprayed with the preparation of active compound at thestated application rates.

The plants were placed in a greenhouse at a temperature of about 20° C.and a relative atmospheric humidity of about 80% to promote thedevelopment of mildew pustules.

Evaluation was carried out 7 days after the inoculation. 0% means anefficacy which corresponds to that of the control, whereas an efficacyof 100% means that no infection is observed.

TABLE Erysiphe test (wheat)/curative Active compound applicationefficacy in % Active compounds rate in g/ha found* calc.** Mefenpyr  250 Trifloxystrobin 125 86 Fluoxastrobin 125 0 Spiroxamin 125 0Prothioconazole 125 43 Tebuconazole 125 57 Mefenpyr + Trifloxystrobin1:5 25 + 125 100 86 Mefenpyr + Fluoxastrobin 1:5 25 + 125 100 0Mefenpyr + Spiroxamin 1:5 25 + 125 86 0 Mefenpyr + Prothioconazole 1:525 + 125 100 43 Mefenpyr + Tebuconazole 1:5 25 + 125 100 57 *found =activity found **calc. = activity calculated using Colby's formula

The invention claimed is:
 1. A method of increasing the microbiocidalactivity of a fungicide comprising treating a seed or a plant with thefungicide and a safener, wherein the safener is mefenpyr diethyl andwherein the fungicide is tebuconazole, wherein the mefenpyr diethyl andthe tebuconazole are applied to the seed or plant in synergisticamounts, wherein the weight ratio of mefenpyr diethyl to tebuconazole isfrom 50:1 to 1:50.
 2. The method according to claim 1 wherein the seedor the plant is treated with a composition comprising the fungicide andthe safener.
 3. The method according to claim 1 wherein the seed istreated with the fungicide and the safener.
 4. The method according toclaim 1 wherein the plant is treated with the fungicide and the safener.5. The method according to claim 1 wherein the seed is in contact withthe fungicide and the safener.
 6. The method according to claim 1wherein the plant is in contact with the fungicide and the safener. 7.The method according to claim 6 wherein the plant is a transgenic plant.8. The method according to claim 1, wherein the weight ratio of mefenpyrdiethyl to tebuconazole is 20:1 to 1:20.
 9. A method of controllingphytopathogenic fungi comprising treating a seed or a plant with afungicide and a safener, wherein the safener is mefenpyr diethyl andwherein the fungicide is tebuconazole, wherein the mefenpyr diethyl andthe tebuconazole are applied to the seed or plant in synergisticamounts, wherein the weight ratio of mefenpyr diethyl to tebuconazole isfrom 50:1 to 1:50.
 10. A method according to claim 9, wherein the fungiis plasmodiophoromycetes, oomycetes, chytridiomycetes, zygomycetes,ascomycetes, basidiomycetes, or deuteromycetes.
 11. The method accordingto claim 9, wherein the fungi is Erysiphe graminis, Pyrenophora teres,or Leptosphaeria nodorum.
 12. The method according to claim 1, whereinthe plant treated is wheat.
 13. The method according to claim 9, whereinthe mefenpyr diethyl and the tebuconazole are applied to the seed orplant simultaneously.
 14. The method according to claim 9, wherein themefenpyr diethyl and the tebuconazole are applied to the seed or plantin succession.
 15. The method according to claim 9, wherein the weightratio of mefenpyr diethyl to tebuconazole is 20:1 to 1:20.